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Abstract
Motor fluctuations are a major focus of clinical managements in patients with mid-
stage and advance Parkinson’s disease (PD). In this thesis, an automated algorithm is
developed to identify those fluctuations (i.e., medication OFF and ON) using wearable
sensors while PD patients are engaging in a variety of daily living activities. Four
different methods are proposed which are supervised learning using Support Vector
machine (SVM) with fuzzy classification, semi-supervised learning using k-means or
using Self-organizing Tree Map Algorithm (SOTM) with fuzzy classification, and
supervised classification using Long short-term memory (LSTM) as a deep learning
method.
A set of temporal and spectral features are extracted from the ambulatory signals
of triaxial gyroscope sensors. After performing dimensionality reduction, the features
are introduced to SVM or clustering methods using k-means or SOTM. Signals of the
gyroscope sensors are passed directly to LSTM network. The developed methods were
evaluated on two datasets that included recordings of 19 PD patients. Two scenarios
were considered: general training/classification and patient-specific where the former
trains and tests the algorithm using subject-based leave-one-out cross-validation, and
the latter trains and tests the algorithm for each patient individually. In addition, for
patient-specific scenarios, the number and placement of sensors is selected for each
patient and this selection is based on the average change in UPDRS score between
ON and OFF medication states and the presence of tremor for that patient.
Overall, patient-specific algorithm resulted in a higher classification performance
when it based on SVM with fuzzy classification (i.e., 80%, 82% and 78% for accuracy,
sensitivity, and specificity of the OFF state, respectively). This algorithm was able to
classify the medication states with high confidence (i.e., accuracy 94.86%, sensitivity
91.94% and specificity 96.83%) for the group of patients with a change of more than 15
in their UPDRS score between the OFF and ON medication states. This results are
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promising and thus this algorithm can be potentially used in routine clinical practice
to improve the quality of this group of PD patients.
In addition to these results, when only one sensor mounted on the ankle was used
in the general training scenario, the algorithm based on LSTM performed better than
SVM with 74.91%, 69.42%, and 80.55% for accuracy, sensitivity, and specificity, re-
spectively. The promising results of LSTM show the potential outcome of developing
deep learning methods in this field.
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Chapter 1
Introduction
1.1 Motivation
Parkinson’s disease (PD) is a chronic progressive neurological disorder that leads to
motor and non-motor impairments [2]. It is the second most common neurodegen-
erative disease after Alzheimer. Motor impairments include hand and leg tremor
while resting, rigidity, reduction in the speed and quantity of spontaneous purposeful
movements (bradykinesia and akinesia, respectively), axial disability, and dysarthria
(speech difficulty). Non-motor abnormalities consist of sleep disturbances and auto-
nomic dysfunctions [3]. The most potent and effective treatment for motor symptoms
is levodopa which is converted to dopamine, the neurotransmitter that is lost with pro-
gressive degeneration of the substantia nigra that is caused by PD. At the beginning
of using levodopa, PD symptoms may totally disappear, but it does not prevent PD
progression. With prolonged treatment, the majority of patients develop motor fluc-
tuations, in which benefit from levodopa wears off between doses, with re-emergence
of bradykinesia and tremor (referred to as OFF medication state), and may cause
abnormal involuntary movements (dyskinesias) at peak dose effect [4] when tremor,
bradykinesia, and other PD symptoms are relatively improved (referred to as ON
state). Motor fluctuations are a major focus of clinical management in patients with
mid-stage and advanced disease [5].
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A variety of assessment methods are used to evaluate response to therapeutic
interventions for motor fluctuations to progressively adjust the frequency and dose
of levodopa for each PD stage that can be different for each PD patient. The first
method is the Unified Parkinson Disease Rating Scale (UPDRS) that includes both
objective clinical exam as well as historical information [5]. This information includes
side effects of therapy such as motor fluctuations (e.g. percentage of the day spent
OFF or ON with dyskinesias). However, for a patient with motor fluctuations, a single
clinical exam is not sufficient to evaluate the spectrum of the motor impairments that
a patient may experience over the course of a typical day. For example, single clinical
exam is not enough to determine how severe the dyskinesias due to the effect of emo-
tional changes in inducing it [3]. In addition, evaluations for invasive treatments such
as deep brain stimulation (DBS) surgery typically require repeated examinations in
clinic or in hospital before and after onset of medication benefit. These repeated visits
are expensive and pose burden to PD patients. Another commonly used assessment
tool for patients with motor fluctuations is the motor diary, in which patients log their
motor status (OFF, ON without troublesome dyskinesia, and ON with troublesome
dyskinesia) every thirty minutes while awake. Motor diaries pose significant burden
to patients and they are subjective [6] and typically used in clinical trials rather than
for routine clinical care. Therefore, there is a need to automate the assessment of the
medication states using a conformable, cheap and objective prediction method.
1.2 Literature Review
The wide availability of wearable inertial sensors (accelerometers and gyroscopes) has
led to active interest in developing tools for assessing PD symptoms and tracking pa-
tient’s motor fluctuations more comprehensively, accurately, and with less burden on
clinicians and patients. PD patients prefer to wear unobtrusive sensors for medication
state assessment even in public instead of logging their medication state to a diary [7].
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Multiple methods that are based on inertial sensors have been proposed and em-
bedded into systems available in the market to detect PD motor impairments [3, 8].
The methods are proposed to detect and assess the severity of tremor [9–17], bradyki-
nesia [9,11,16,18,19], and dyskinesia [10,12,13,17,18,20–26]. Some of these methods
accurately detect PD motor impairments during constrained and unconstrained activ-
ities. The results of these methods can be helpful for neurologists if the requirement is
individually tracking each one of the symptoms. However, adjusting the medication
to reduce motor fluctuations requires the PD physicians to spend a lot of effort and
time to further analyze the severity of all PD symptoms and dyskinesias together
over time to find the intervals of the ON and OFF states during the day. Therefore,
there is a need to detect the medication states in addition to detecting and assessing
severity of PD symptoms and dyskinesia.
There are a variety of approaches in the published literature that are applied
to classify medication treatment status (ON versus OFF) [9, 17, 24, 27–32]. They
use accelerometer and gyroscope sensors that are worn on different parts of the
body (wrist [9, 27, 31, 32], leg [9, 27, 28] or/and waist or trunk [9, 17, 24, 27–30]), and
they use different windows sizes in the range of 3 seconds to 10 minutes with or
without overlap for signal segmentation. For feature extraction, [9, 27] extract tem-
poral features, whereas [17, 24, 28–32] extract both temporal and spectral features.
Multiple supervised classification methods are used: linear discriminant (threshold-
based) [24,27–29], Support Vector Machine (SVM) [17,30]), Artificial Neural Network
(ANN) [32], logistic regression [9], and deep learning [31].
Some of these approaches are activity-independent and providing continuous mon-
itoring but they achieved accuracy lower than 80% [9, 17, 27, 31, 32] which is not ad-
equate to be used in the routine clinical practice. Other methods trade continuous
monitoring with performance and they achieved accuracy over 90%, but only when
patients’ activities are constrained [24, 28–30]. For example, [28] excluded periods of
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walking to minimize misclassification and they did use a held out set for validation.
That means other periodic activities may be also misclassified and should be excluded
(e.g. teeth brushing and cutting groceries). In addition, [24, 30] and [29] limit the
analysis to period of walking, or both walking to detect bradykinesia and non-walking
to detect dyskinesia, respectively. Therefore, algorithms that can accurately classify
medication status during the variety of activities that people routinely carry out in
their daily lives have thus far been elusive.
In addition, the majority of the approaches to date have involved classification
algorithms that are trained using data from a group of well-characterized patients, and
then generalized to individual patients for testing [9,17,24,31,32]. In this classification
problem, these approaches may not generalize well because the accuracy is likely
impacted by the significant variability between patients with respect to:
• Somatotopy (which body parts are impaired that may require different sensor’s
placement on the patient body and different number of sensors).
• Phenomenology (which of the different motor impairments are present, for in-
stance, dyskinesia appears in 50% of PD patients with prolonged treatment
with levodopa [3]).
• Severity of PD symptoms (e.g. one patient’s best movement speed may corre-
spond to a less advanced PD patient’s worst movement speed).
This variability requires different classification models for each patient. [27–30] adapted
their models for specific group of patients or for each patient. [28] categorized their
datasets into two groups of patients with and without tremor, calculated specific
threshold for the linear discriminant method for each of them, and concluded that the
sensor placement on leg for first group and on trunk for second group is more informa-
tive. [29] used patient-specific threshold for bradykinesia detection only, whereas [30]
and our previous works [33,34] trained patient-specific algorithm to detect the medica-
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tion states. The advantage of our previous work over [30] is predicting PD medication
states without constraining patient’s activities.
In this thesis, patient-specific algorithm is developed for automatic detection
of the motor states of patients with Parkinson’s disease without constraining pa-
tients’ activities. Four methods that include using shallow or deep learning are pro-
posed to perform the classification. In addition, a comparison is completed between
patient-specific and general training algorithms. The algorithm uses gyroscope sig-
nals recorded by wearable sensors and can help clinicians to assess different states of
PD as part of the routine clinical practice.
1.3 Contributions
The contributions of this thesis are summarized as follows:
1. Developed patient-specific algorithm for automatic detection of the motor states
of patients with Parkinson’s disease without constraining patients’ activities.
2. Developed two supervised methods based on Support Vector machine (SVM)
with fuzzy classification of feature vectors with temporal dependencies, and
based on Long short-term memory (LSTM) that is used for the first time in the
detection of PD medication states.
3. Developed two semi-supervised methods based on k-means and Self-organizing
Tree Map Algorithm (SOTM).
4. Integrated the three dimensional representations of the gyroscope signal instead
of using their magnitude for all the developed methods.
5. Extracted features and developed dimensionality reduction method based on
statistical analysis and Principal Component Analysis (PCA).
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6. Developed novel quantitative metric denoted as strength factor and used in the
semi-supervised methods to perform binary classification.
7. Proposed a novel approach for selecting the number and placement of the gy-
roscope sensors for each patient specifically to perform medication state classi-
fication.
8. Evaluated the proposed methods using two scenarios: general training/classification
and patient-specific, and using two datasets of 19 PD patients.
9. M. Hssayeni, M. Burack, B. Ghoraani, "Automatic Assessment of Medica-
tion States of Patients with Parkinson’s Disease Using Wearable Sensors", in
the proceedings of the 38th Annual International Conference of the IEEE En-
gineering in Medicine and Biology Society, Pages: 6082-6085, Orlando, August
2016.
10. M. Burack, M. Hssayeni, B. Ghoraani, "Individualized classification algo-
rithms for OFF and ON levodopa motor states from continuous wearable motion
sensor data in Parkinson disease with motor fluctuations", at the 30th Annual
Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson Disease
and Other Movement Disorders, September 2016, Portland, OR.
11. V. Ramji, M. Hssayeni, M. Burack, B. Ghoraani, "Parkinson’s Disease Medi-
cation State Management Using Data Fusion of Wearable Sensors", in the pro-
ceedings of the International Conference of the IEEE Biomedical and Health
Informatics, pp. 193-196, Orlando, February 2017.
12. Received National Science Foundation (NSF) award for young professionals dur-
ing IEEE Engineering in Medicine and Biology Society Conference (EMBC 16)
for our work in assessing PD medication states.
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1.4 Organization of The Thesis
The thesis is organized in five chapters. Brief information about each chapter is
mentioned below:
• Chapter 1. Introduction : explains the motivation behind the work that
has been performed toward completing the thesis, literature review about the
proposed tools and methods to assess PD symptoms and medication states, and
the contribution of this thesis.
• Chapter 2. Materials : describes popular machine intelligence methods
that are the basis for the proposed methods in chapter 3, and illustrates the
datasets that were used in this thesis in details. The methods are Support
Vector Machine (SVM), clustering using k-means and Self-organizing Tree Map
(SOTM), and Long Short-Term Memory (LSTM).
• Chapter 3. Proposed Methods: describes four proposed method to assess
PD medication states in details. These methods are supervised classification
using SVM and LSTM, and semi-supervised classification using k-means and
SOTM.
• Chapter 4. Results and Discussions : explains the metrics that is used
to test the proposed methods, feature analysis, results for each of the methods
using the two datasets, and comparisons between the methods and between the
results of this thesis with other studies.
• Chapter 5. Conclusion : mentions a brief summary about the thesis and the
obtained results then concludes the outcomes and future work.
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Materials
This chapter starts by describing the datasets that are used in this thesis in de-
tails. The second section has a brief introduction about machine intelligence and
the required steps to build a model to solve a classification or regression problems.
In addition, supervised classification method using support Vector Machine (SVM)
and Long short-term memory (LSTM), and clustering methods are explained. These
methods are the base for proposed methods in next chapter.
2.1 Datasets
2.1.1 Dataset1
Monitoring PD motor impairments during a variety of activities motivated designing
a protocol [25, 26] to collect the first dataset that is used in this thesis. Fifteen
patients who were diagnosed with idiopathic PD participated in that study and these
patients were also showing choreatic peak-dose dyskinesia. The upper part of Table
2.1 includes the demographics of the twelve subjects that are included in the data
analysis in this thesis. Three subject are excluded from the analysis because they
didn’t show motor fluctuation between the two states during the scheduled time to
record the data.
KinetiSense motion sensor unit (Great Lakes NeuroTechnologies Inc., Cleveland,
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OH) was used in the study. It is composed of a triaxial accelerometer and triaxial
gyroscope. The dimensions of the unit are 22 × 16 × 10 mm and it weights 10
g. The sampling rate of this unit is 128 Hz. In addition to the sensor units, a
local computer was used to save the data that was recorded by the sensor units and
wirelessly transmitted to the computer.
Before starting the experiment, patients with mild PD were asked to hold their
medication after 10 pm of the day before the experiment, whereas patients with more
advanced PD were scheduled to do the experiment at the end of a dose interval.
Therefore, the experiment started the first round while the patients were in the OFF
state. The patient were instrumented with ten of the sensor units that were mounted
on the left temple of head, C7 spinous process (trunk), dorsum of each wrist, each
ankle, and frontal surface of each thigh and arm. Figure 2.1 shows the locations of
the sensors that are included in the data analysis in this thesis.
The experiment was divided into four rounds for each subject. In each round, the
subjects were instructed to perform seven daily living activities which were walking,
resting while sitting, drinking from a cup for multiple times, dressing by putting on
a coat and taking it off, hair brushing, unpacking groceries, and cutting food using
a knife and fork. Each of these activities were about 15-60 seconds. At the end of
each round, Unified Parkinson’s Disease Rating Scale (UPDRS) was examined by
a clinician to categorize each round as OFF or ON. Following the recording in the
first round, the subjects took their prescribed anti-parkinsonian medications (without
adding booster dose) and went back to their typical medication schedule. After
taking the medication, next three rounds were recorded once per hour. All the tasks
were videotaped and the videos were used later by two blinded movement disorder
experts to score dyskinesias using the modified Abnormal Involuntary Movement
Scale (mAIMS).
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Table 2.1: The demographics information of the analyzed subjects in this thesis for both
first and second datasets. DBS: number of subjects with Deep Brain Stimulation, UPDRS:
Unified Parkinson’s Disease Rating Scale, PDYS-26: 26-item Parkinson’s Disease Dyskinesia
Scale, LEDD: Levodopa Equivalent Daily Dose
Dataset 1
# Analyzed Subjects 12 Sex
9 M
3 F
Age average (yr)
Age range (yr)
55.8
42-77
Disease duration (yr)
Disease duration range (yr)
9.4
4-14
DBS
6 with
6 without
% Change in UPDRS
% Change range
52.8
29-69
PDYS-26
PDYS-26 range
35.6
1-79
LEDD (mg)
LEDD range
1225
510-1930
Dataset 2
# Analyzed Subjects 7 Sex
5 M
2 F
Age average (yr)
Age range (yr)
58.7
48-68
Disease duration (yr)
Disease duration range (yr)
10.6
8-15
DBS
3 with
4 without
% Change in UPDRS
% Change range
51
15-85
PDYS-26
PDYS-26 range
36.84
11-54
LEDD (mg)
LEDD range
1380.9
862.5-1975
2.1.2 Dataset2
The second dataset that is used in this thesis was collected under a protocol [35],
which was designed to continuously monitor PD symptoms while PD patients are
engaging in daily living activities. Thirteen PD patients participated in the study.
These patients had a history of dyskinesias at the peak dose of levodopa. The lower
part of Table 2.1 includes the demographics of the seven subjects that are included in
the data analysis in this thesis. The other subjects were excluded from the analysis
in this thesis because OFF and ON states were not achieved for some of the subjects
during recording session, and the data was not finalized for others at the time when
11
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Back Front
Dataset 1
Back Front
Dataset 2
Figure 2.1: The locations of the motion units on each body part for the first and second
datasets. The signals that were recorded by only these motion units are used in the data
analysis.
the experiments of this thesis were performed.
KinetiSense motion sensor unit (Great Lakes NeuroTechnologies Inc., Cleveland,
OH) was used in the study. It is composed of a triaxial accelerometer and triaxial
gyroscope. The sampling rate of this unit is 64 Hz. In addition to the sensor units,
a local computer was used to save the recorded and wireless-transmitted data.
The experiment was started while the patients were in their OFF state. Therefore,
the study was either in the morning before the patients take their normal dose of
levodopa or later in the day at the end of a dose for patients with known end of
dose time. The patient were instrumented with eight of the sensor units that were
mounted on index finger of each hand, dorsum of each wrist, each ankle, and frontal
surface of each thigh. Figure 2.1 shows the locations of the sensors that are included
in the data analysis in this thesis.
The experiment venue consisted of six stations to mimic activities of daily living
(ADL). These stations were: dressing station where subjects put on and take off shoes
and coat, entertainment station where subjects talk, read, or watch TV while sitting
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on a couch, snack station where subjects prepare and eat a snack and/or drink a
beverage while sitting at a table, hygiene station where subjects comb their hair and
brush their teeth, laundry station where subjects fold laundry from a basket, and
desk work station where subject write and work on a computer.
After determining that the subjects in the OFF state by clinical exam and physi-
cian’s direct observation, the subjects were asked to cycle through all the station and
recording the data started. After completing all the stations at least once, the sub-
jects were instructed to take their normal prescribed dose of PD medication. Subjects
were left to perform the activities that they prefer before their medication starts its
effect. After confirming that they were in the ON state by physician’s direct obser-
vation, they were asked again to cycle through all the stations at least once. The
total time for the experiment for each subject was about two hours of ADL tasks.
In addition to these activities, UPDRS exam was performed by the physician at the
beginning of the study for all the subjects. The ADL tasks were videotaped and used
for subsequent offline clinical ratings by blinded movement disorder expert, and for
annotating the ADL tasks that will be used in the training part of the developed
algorithm and in analyzing its performance.
2.2 Methods
In machine intelligence, supervised classification or regression algorithms are con-
structed and trained on labeled samples (feature vectors) to predict the labels or
classes of unknown samples. If only small amount of the training samples are labeled
and the majority of these samples are unlabeled, or if unlabeled data are clustered
prior to use their labels then the developed algorithms are called semi-supervised
learning. If only unlabeled data are used in training the models, then this kind of
learning is called unsupervised such as clustering methods.
The first step to solve a problem using machine intelligence is collecting the raw
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data and starting labeling it if that is possible. This data can be images, signals,
text, or other type of representation. The second step is filtering or refining the data.
The next step is determining the boundaries of patterns that present in the data and
relate to the problem which is known as segmentation such as segmenting word or
syllables, and segmenting accelerometer signal to cover a specific activity. The last
step prior to choose a classification or regression model is dimensionality reduction
that includes feature extraction and selection. Feature extraction is the process of
deriving new values from the segmented data to form sample or feature vectors that
will be used to train, test and validate the classification or regression models. In the
next sections, different methods for supervised and unsupervised classification are
explained which are Support Vector Machine (SVM), clustering using k-means and
Self-organizing Tree Map Algorithm (SOTM), and Long short-term memory (LSTM).
2.2.1 Support Vector Machine
SVM is a supervised classification and regression model [36]. The basic concept of
this model is constructing a separating hyperplane that has the maximum margins
around it or between the samples of two classes as shown in Figure 2.2. The position
of a new sample on each of the hyperplane’s sides decides which class it belongs to.
If the following equation is true for feature vector x, then it is called support
vector (Xsv1×NF , where NF is the number of features) and it bounds the hyperplane
(support vectors are denoted with dotted circles in Figure 2.2):
∣∣W TXsv + b∣∣ = 1 (2.1)
whereW1×NF is perpendicular vector to the hyperplane. To optimize the margin that
is defined as 1||W || (where ||W || is the second norm of W ), quadratic programming is
used to optimize Lagrange formulation and find Lagrange multipliers (α). α’s that
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are calculated and not zero are for Xsv’s and they are used to find W by applying
the following equation:
W =
n∑
i=1
α(i)y(i)Xi (2.2)
where n is the number of support vectors (Xn×NF ) in the training data, and y is the
predefined labels of XSV ’s (+1 or -1). The calculated W above is used with any Xsv
in the following equation to find the bias b:
ysv(W
TXsv + b) = 1 (2.3)
The calculated W and b that defined the hyperplane will be used to find the decision
value (DV ) for the test feature vector xt1×NF as follow:
DV = W Txt + b (2.4)
If DV is ≥ 0 then xt belongs to the positive class, else it belongs to the negative class.
Classes that are separable in low dimensional space using straight-line hyperplane
can follow the previous method. However, to discriminate between classes in multiple
problems, feature space needs to be rotated to a higher dimensional space. That
means the inner product of the feature vectors in the new high dimensional space while
applying the Quadratic programming will be computationally expensive. However,
the kernel trick can perform the inner product without transforming into or out of the
higher dimensional space and solves the previous issue. Common kernels are linear,
polynomial, sigmoid and Radial Basis Function (RBF) that is defined as:
K(xi, xj) = e
−γ(xi−xj)2 (2.5)
where gamma γ is a free parameter that is > zero. Another parameter that is used in
this model is the c parameter that works as a regularization parameter in case there
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CHAPTER 2. MATERIALS
Feature 1
F
ea
tu
re
 2
Separating Hyperplane
Positive Class 
Negative Class 
Support Vectors 
Figure 2.2: An example of using a separating hyperplane between three dimensional feature
vectors of two classes to depict the concept of SVM. The support vectors that specify the
largest margin are annotated with dotted circles.
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are feature vectors that violate the margin. Sufficient high value of c prevents the
feature vectors from violating the margin and leads to including more feature vectors
as support vectors.
The implementation of SVM model does not provide posterior probability. There-
fore, a parametric form of sigmoid is proposed by Platt et al. [37] for this purpose as
follows:
P (y = 1|DV ) = 1
1 + eA×DV+B
(2.6)
where P (y = 1|DV ) is the probability of class y given the decision value DV, and
A and B are two scalar parameters that are calculated by minimizing the negative log
likelihood that is based on the training set ({DVi, yi}i=1:NW , where NW is the number
of windows or feature vectors in the training data).
2.2.2 Clustering
Clustering is unsupervised learning method that is applied on unlabeled data to group
the samples based on their similarity. Two clustering methods are employed in this
thesis to obtain K clusters (C) as explained below:
2.2.2.1 k-means
K-means is a well-known iterative clustering algorithm that assigns n feature vec-
tors ( ~fv1×NF ) to K pre-defined number of clusters ({Ck}k=1:K) with K centroids
({~Ck×NF }k=1:K).
The algorithm consists of the following steps [38]:
1. Initialize the centroids of the K clusters by randomly choosing K feature vectors
from the training dataset.
2. Compute the Euclidean distance between all the feature vectors to all the cen-
troid.
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3. Assign each feature vector to the nearest cluster (i.e. its centroid has the mini-
mum Euclidean distance to ~fv).
4. Update the centroids of the K clusters by calculating the average of all the
feature vectors in each cluster.
5. Repeat from step 2 to 4 until one of the following condition:
(a) The assigned ~fv’s to each cluster do not change.
(b) The maximum number of iterations is reached.
In addition to the previous steps, multiple replicates can be used to find a solu-
tion that represent a global minimum by starting with different initial ~fv’s for the
centroids in each replicate. The selected replicate has the lowest total sum of Eu-
clidean distances between the ~fv’s and the centroids of the clusters to whom they
were assigned.
2.2.2.2 Self-organizing Tree Map Algorithm
SOTM is a tree structured neural network in which competitive learning is imple-
mented. The tree starts by adding a root node for the first random feature vector
and then it grows by adding new nodes for the ~fv’s that show dissimilarity to the clos-
est node. Node creation is governed by dynamic hierarchical control function H(r)
that decays with each iteration (r) to explore different level of similarity between
the ~fv’s for each node. The resolution of clustering can be imposed by forcing H(r)
to stop at a specified level H(∞). H(r) can also operates in other three modalities
proposed by [39]. The exponential H(r) is represented by [39]:
H(r) = H(0)(1− e− rτH ) (2.7)
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where H(0) is the sum of the ranges of all the features, and τH = 2 ∗ NW where
NW is the number of windows in the training dataset. In addition, the weights in
each node are adjusted using a learning rate α(r) that decays with each iteration till
the weights’ convergence. Different modes of α(r) is explained by [39]. The preferred
mode is the global reset upon node generation when α(r) is shared for all the nodes
as shown in part C of Figure 2.3.
The SOTM process can be explained as follows [39]:
1. Initialize the root node weights ~w1(r) with randomly selected ~fv(r), and set the
number of nodes (K) and iteration r to 1.
2. Take another ~fv(r) randomly at r + 1 and find the closest node (k∗) based on
the minimum Euclidean distance (dk∗):
dk∗( ~fv, ~wk∗) =
K
min
k=1
‖ ~fv(r)− ~wk(r)‖ (2.8)
3. If dk∗ less than or equal to H(r), then update the node k∗ weights using the
following equation:
~wk∗(r + 1) = ~wk∗(r) + α(r)[ ~fv(r)− ~wk∗(r)] (2.9)
else K = K + 1, spawn a child node to k∗ and initialize its weights (wK(r))
from the given ~fv(r).
4. Check the following conditions if any is true, then stop the algorithm and output
{~wk}k=1:K as the clusters’ centroids ({~Ck×NF }k=1:K), else repeat from step 2:
(a) Maximum number of iteration (MaxItr) or clusters is reached. MaxItr
equals maximum number of epoch multiplied by NW .
(b) The tree structure does not change significantly.
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An example of clustering using SOTM on randomly generated 2-dimensional data
is shown in Figure 2.3. Part A and B of this figure show data before and after
clustering using SOTM, respectively. Three clusters were detected with the tree that
represents the relationship between them. The used modes for H(r) and α(r) were
the stepped H(r) with irregular period and the global reset upon node generation,
respectively, which are shown in part C and D in the figure.
2.2.3 Long Short-Term Memory
The detection of patterns that have temporal dependencies requires the Artificial
Neural Network (ANN) to create hidden states to save the output of the previous
time step. ANN with this kind of abilities is known as Recurrent Neural Network
(RNN). Adding memory cells to the architecture of the standard RNN enables it
to exploit patterns presented in long duration of time. The architecture is known
as Long Short-Term Memory (LSTM) [40]. In addition, LSTM solves the vanishing
gradient problem that occurs if error gradients are back-propagated through multiple
time steps.
Multiple architectures of LSTM have been proposed in recent years to refine the
original LSTM. In this thesis, the architecture proposed by [1] is used and is shown in
Figure 2.4. This architecture consists of the main part which is the memory cell (ct
at time step t), and four gates. These gates are the input gate (i), input modulation
gate (g), forget gate (f), and output gate (o). Input gate determines and writes
the importance of current input at time step t (xt) and past hidden state (ht−1),
modulation gate summarizes both xt and ht−1 and this summary will be governed
by the input gate, forget gate determines which historical data should be reset and
when, and output gate determines which part of the memory or internal state (ct−1) is
important to be output and use for next time step. The operations that are performed
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Figure 2.3: Randomly generated 2-dimensional data before and after clustering using
SOTM are shown in part A and B, respectively. During clustering using SOTM, the global
α(r) reset upon node generation and the dynamic hierarchical control function H(r) that
decays with each iteration (r) were saved and shown in Part C and D, respectively.
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on xt using ht−1 and ct−1 from previous time step are defined as follow:
it = σ(Wxixt +Whiht−1 + bi) (2.10)
gt = φ(Wxgxt +Whght−1 + bg) (2.11)
ft = σ(Wxfxt +Whfht−1 + bf ) (2.12)
ot = σ(Wxoxt +Whoht−1 + b0) (2.13)
ct = ftct−1 + itgt (2.14)
ht = otφ(ct) (2.15)
whereWab is the ab weight matrix (a = {x, h} and b = {i, g, f, o}), σ is the logistic
sigmoid function, and φ is the tanh activation function. If multiple LSTM layers are
used, then the inputs of top layers are ht of the layers below them. After updating
the internal state of the model and determining ht of last layer, the output (yt) is
calculated using the following linear transformation:
yt = Whyht + by (2.16)
After obtaining yt, back-propagation through time (BPTT) is used during training
stage. Regularization methods can also be used here to prevent the model from
overfitting the training data. These methods are training using mini-batches, dropout
layers [1] and weight decay technique (L2 norm regularization).
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Figure 2.4: LSTM cell representation in one layer as proposed by [1] during forward
propagation at time step t. Different colors are used to show the data flow through out
different gates. Fully connected and Soft-max layers are shown on top of the LSTM cell.
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Proposed Methods
After collecting the data, this chapter first describes type of sensors that are se-
lected for data analysis and why, and the preprocessing steps that precede each
of the proposed methods. Second, it describes the proposed methods which are:
supervised classification using SVM, semi-supervised classification using k-means,
semi-supervised classification using SOTM, and supervised classification using LSTM.
Figure 3.1 shows the main parts in the first three proposed methods starting from
preparing the data, extracting the feature vectors that are used to train and test
SVM or semi-supervised classier, performing dimensionality reduction using two con-
secutive approaches which are statistical analysis and Principal Component Analysis
(PCA), and training and testing fuzzy classifiers. For the last section that describes
classification using LSTM, feature extraction and dimensionality reduction are not
performed prior to train the deep model.
3.1 Sensor Selection and Preprocessing
Each of the motion units that were used in the previous datasets contained two types
of motion sensors which are gyroscope and accelerometer. Gyroscope is less affected
by vibration and mechanical noise than accelerometer and it is better reflecting limb
rotations that occur during tremor and dyskinesia [25]. Therefore, gyroscope record-
ings can be used later to accurately detect these PD symptoms. In addition, in
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Tsipouras et al. work [23], Experiments 6 and 8 using gyroscope sensors showed bet-
ter accuracy of levodopa-induced dyskinesia (LID) classification than experiments 5
and 7 using accelerometer sensors, respectively. Therefore, gyroscope is chosen to
assess the PD medication states in this thesis and also using one sensor will increase
battery life for the system when it will be used in daily life.
Bandpass FIR filter with 3dB cutoff frequency between (0.5-15Hz) is used to filter
the three axes of the recoded signal of each sensor to eliminate low and high frequency
noise.
A. Gyroscope Sensors 
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Figure 3.1: Overall Project Design that shows the different parts of the algorithm and
how the data flows through it to make the final assessment of the PD patients’ medication
states.
3.2 Supervised Classification: SVM
The well-known SVM approach (refer to Section 2.2.1) has been used to perform
the medication state classification in the first method. SVM has been used before
successfully for classification problems related to PD [17, 24] or activity recognition
[41–44] using data extracted from inertial sensors. Before training SVM model, signal
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Figure 3.2: Segmenting the recorded signal using a sliding 5-second window with 4-second
overlap.
segmentation, feature extraction, and dimensionality reduction are performed. The
following sections describe each of these steps in details.
3.2.1 Segmentation
The last step of preparing the signal is segmenting the signals into 5-second windows
with 4-second overlap between the adjacent windows to do further analysis as shown
in Figure 3.2. Using 5-second as window length is found to be suitable to detect
tremor, bradykinesia, and dyskinesia as a result of Patel et al. work [45].
3.2.2 Feature Extraction
Different features are extracted from each window ({Wi}i=1:NW , where NW is the
number of windows) for each of the sensors’ axes (X,Y, and Z) separately to retain
directional information in the analysis, and also for a combination of two axes. The
features are selected to distinguish the following PD symptoms or levodopa side ef-
fects, or between the two states directly: bradykinesia, tremor, and dyskinesia. The
peak effect of these symptoms presents in the OFF state with relatively lower or no
effect in the ON state. Some of the features were previously identified as relevant
to PD symptoms [10–14, 17, 18, 21–25, 28, 33, 34, 46] and others are new developed
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features.
Candidate features to detect bradykinesia and dyskinesia are:
1. Average jerk is calculated as the mean of the second derivative of the angular
velocity readings in each window (Wi) to represent their rate of change. Values
of average jerk that are close to zero indicate the presence of bradykinesia and
high values indicate the presence of sudden movements that can be dyskinesia.
2. Signal power 1-4 Hz [24,34] is calculated by taking the Fast Fourier Transform
(FFT) for each window (Wi) to convert them to their representations in the
frequency domain (Wi(f)) and then calculating the summation of the powers
of frequencies in the interval (1 to 4 Hz). High values of this feature are an
indication of the presence of dyskinesias and vice versa in case of bradykinesia.
3. Standard deviation (σ) [17, 23, 47, 48] represents the amount of variation in
readings of angular velocity for each window (Wi). Low σ is an indication of
bradykinesia whereas high σ is used to predict dyskinesias which are related
wider range of angular velocities. σ is calculated as follows:
{σWi}i=1:NW =
√√√√ 1
N − 1
NS∑
n=1
|Wi(n)− µWi |2 (3.1)
where NS is the number of samples in Wi, and µWi is the mean of Wi.
4. Temporal Shannon entropy [23,49] finds the complexity and randomness in the
readings of angular velocity in a given window Wi. High complexity indicates
dyskinesias present and low entropy indicates bradykinesia. The entropy is
defined as follows:
{HWi}i=1:NW = −
∑
b∈Bi
(p(b) ∗ log2(p(b))) (3.2)
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where Bi is the histogram bin set {-400, -396, -392, ..., 400} for Wi which are
found to be effective in this thesis, and p(b) is the bin b probability in Bi.
5. Sample entropy (SampEn) [21, 50] is a measure of noise or dissimilarity in a
given window (Wi). It is calculated by first segmentingWi into vectors of length
m and m+1 that is defined as Xm(τ) = {Wi(τ),Wi(τ+1),Wi(τ+2), ...,Wi(τ+
m− 1)} where τ is the lag. The next step is calculating SampEn as follows:
{SampEnWi}i=1:NW = − log
∑NS−m−1
j=1
∑NS−m−1
k={j+1|d[Xm+1(j),Xm+1(k)]<r} 1∑NS−m−1
j=1
∑NS−m−1
k={j+1|d[Xm(j),Xm(k)]<r} 1
(3.3)
where d[x, y] is the Chebyshev distance and every time it is less than r then
increment the nominator or denominator by one, and r is the tolerance. m is
set to two and r to 20% of the standard deviation of the gyroscope signal. The
presence of non-dominant segments in Wi that is related to dyskinesia leads to
high SampEn, whereas bradykinesia results in low SampEn that is close to
zero.
6. Gini Index is a value between 0 and 1 that also finds moving complexity in a
given window (Wi) and is calculated using the following equation:
{GWi}i=1:NW = 1−
∑
b∈Bi
p2b (3.4)
7. Skewness (γ1) [41,42,48,49,51] is an asymmetry measure about the mean of gy-
roscope readings inWi. Readings while patients are suffering from bradykinesia
have γ1 close to zero. γ1 is calculated using the following equation:
{γ1Wi}i=1:NW =
1
N
∑NS
n=1(Wi(n)− µWi)3
σ3Wi
(3.5)
8. Kurtosis (k) [41, 42, 48, 49, 51] represents a measure of how much a recorded
28
CHAPTER 3. PROPOSED METHODS
signal while patients are performing a specific activity is prone to outliers. The
outliers in this case can be dyskinesias. k is defined as:
{kWi}i=1:NW =
1
N
∑NS
n=1(Wi(n)− µWi)4
σ4Wi
(3.6)
The following features are extracted for tremor as follow:
9. Signal power 4-6 Hz [14,34] is calculated by taking the Fast Fourier Transform
(FFT) for each window (Wi) to convert them to their representations in the
frequency domain (Wi(f)) and then calculating the summation of the powers
of frequencies in the interval (4 to 6 Hz). According to UK Parkinson’s Disease
Society Brain Bank clinical diagnostic criteria, Parkinsonian rest tremor is in
4-6 Hz range [52].
10. Percentage of the powers for frequencies > 4Hz [28] is calculated by taking the
Fast Fourier Transform (FFT) for each window (Wi) to convert them to their
representations in the frequency domain (Wi(f)) then find the power percentage
of frequencies > 4 Hz.
11. The number of autocorrelation peaks is calculated by first calculating the au-
tocorrelation for a given window Wi as follows:
{RWi(τ)}i=1:NW =
1
NS−1
∑NS−τ
t=1 (Wi(t)− µWi)(Wi(t+ τ)− µWi)
σ2Wi
(3.7)
where τ is the lag (τ = 1 : NS − 1). The second step is counting the number
of positive peaks in the autocorrelation signal for that window. The presence
of tremor in a given window results in high number of peaks related to tremor
frequency for each patient.
12. The sum of autocorrelation peaks is calculated by first calculating the auto-
29
CHAPTER 3. PROPOSED METHODS
correlation for a given window Wi using equation (3.7). The second step is
summing the positive peaks in the autocorrelation signal for that window. This
feature helps differentiate between tremor and periodic activities like brushing
teeth.
13. Lag of the first autocorrelation peak [10,12,13] is calculated by first calculating
the autocorrelation for a given window Wi using equation (3.7). The second
step is recording the lag that is associated with the first peak (excluding the
peak at the origin) in the autocorrelation signal for that window. Tremor has
a small lag because of it is a fast periodic symptom.
Additional features are extracted for differentiate between the two state in gen-
eral as follow:
14. Signal power 0.5-15 Hz is calculated by taking the Fast Fourier Transform (FFT)
for each window (Wi) to convert them to their representations in the frequency
domain (Wi(f)) and then calculating the summation of the powers of frequencies
in the interval (0.5 to 15 Hz). High values of this feature are an indication that
the patients are in their ON state when they move in faster pace relatively than
their OFF state.
15. Peak-to-peak is the difference between the means of maximum and minimum
20 samples in each window (Wi). Slow movement as a result of OFF state will
lead to small range of angular velocity.
16. First autocorrelation peak is calculated by first calculating the autocorrelation
for a given window Wi using equation (3.7). The second step is recording the
autocorrelation value at the lag that is associated with the first peak (excluding
the peak at the origin). The intuition behind this feature is that the specific
activities, that the patients are doing in the ON state, flow easily and with more
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correlation in comparison to the activities in the OFF state while the patients
are suffering from hypokinesia or rigidity.
17. The mean value for each window (µWi) [18, 41, 42, 48, 51, 53–55] is low in the
OFF state due to the slow movement and relatively high in the ON state.
18. Cross-correlation (ρWXi WYi ) [48, 53, 54] a symmetry measure between X and Y
axes of the recorded gyroscope signal and is calculated as follows:
{ρWXi WXi }i=1:NW =
1
N−1
∑NS
n=1 (W
X
i (n)− µWXi )(W Yi (n)− µWYi )
σWXi σWYi
(3.8)
where WXi and WXi are the recorded windows for X and Y axes, respectively.
PD patients tend to bend their hands and/or legs in the ON state in a way
that is different than their limbs direction in the OFF state. This and next
two features are designed to capture this behavior to differentiate between the
two states. In addition, cross-correlation is used before to differentiate between
walking and going up stairs [48], so in this thesis, it can also help discriminating
between leg dyskinesias and leg periodic activities.
19. Cross-correlation (ρWXi WZi ) between X and Z axes [48,53,54].
20. Cross-correlation (ρWYi WZi ) between Y and Z axes [48,53,54].
21. Spectral entropy (SH) [22,23,44,53,54] finds complexity in the spectrum {Wi(f)}i=1:NW .
It is calculated by first finding the normalized power spectral density for each
window in Wi(f) for the frequencies (f) between 0.5 and 15 Hz as follows:
{PWi(f)}i=1:NW =
1
NS
|Wi(f)|2
1
NS
∑15
f=1 |Wi(f)|2
(3.9)
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and then applying the following equation:
{SHWi}i=1:NW = −
15∑
f=1
(PWi(f) ∗ log2(PWi(f))) (3.10)
22. The peak in the power spectral density [14, 25, 46] for each window in Wi(f)
where f between 0.5 and 15 Hz. With the help of the frequency associated with
the peak power (next feature), they can detect the dominant PD symptom or
normal activity. In addition, Weiss et al. found that PD patients in the OFF
state have lower dominant frequency with lower power than their ON state [46].
23. Dominant frequency [11,46] is associated with the peak in power spectral density
for each window in Wi(f) where f is between 0.5 and 15 Hz.
24. The second peak in the power spectral density for each window in Wi(f) where
f is between 0.5 and 15 Hz. The intuition behind this and next feature is
to record the power and frequency of non-dominant PD symptom or normal
activity that can help differentiating between the two states.
25. Secondary frequency is associated with the second peak in power spectral den-
sity.
3.2.3 Dimensionality Reduction
If it is supposed that only one sensor for each patient is used to extract the features,
then sixty nine features will be extracted for the three axes. High dimensional feature
space makes classification models overfit the training data and do not generalize well.
This is the first reason for applying dimensionally reduction techniques. The second
reason is that some of the features may not perform as proposed due to the kind of
symptoms shown by the PD patients who participated in the collected dataset, the
sensor locations or due to the orientation of the gyroscope’s axes. The third reason
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is that some of the extracted features are correlated between each other due to the
correlation that can happen between the sensor axes. Statistical analysis is applied
first on the extracted features to pick the features that discriminate will between
ON and OFF state. After selecting good features, the next step is reducing the
correlation between the features which is performed by apply principal component
analysis (PCA).
3.2.3.1 Statistical Analysis
Statistical analysis approach is used to select relevant features to discriminate between
the two states and it is applied on the features that were extracted from the training
data only. The second advantage of this approach is determining a probability value
of how good each feature that can be used for further analysis of the association
between the patients’ PD symptoms and the selected features. The first step is
determining if the samples that represents the OFF state in each of features are
normally distributed using Anderson-Darling test [56], and the same normality check
is applied on the samples that represents the ON state. The second step is performing
one the following statistical hypothesis tests: Wilcoxon rank sum [57] or unpaired t-
test [58]. The rank sum and t-test evaluate the hypothesis that the ON and OFF
population in each feature come from a distribution of equal median or from a normal
distribution with equal mean and variance, respectively. A p-value is obtained from
both tests and p < 0.05 values means the ON and OFF samples in each feature are
coming from two separable distributions. If one of the ON or OFF populations for
a given feature is not normally distributed, then Wilcoxon rank sum is performed,
else if both ON and OFF population have normal distribution, then unpaired t-test
is performed. Only the significant features (p-value < 0.05) were included in the
analysis.
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3.2.3.2 Principal Component Analysis
After performing statistical analysis and in order to reduce the dominance of the fea-
tures with high numerical values during the classification stage, the selected features
(FNW×NF ) that were extracted from {Wi}i=1:NW are normalized (nF ) by applying the
following equation:
{nFk}k=1:NF =
Fk − µFTk
σFTk
(3.11)
where NF is the number of the selected features, µFTk and σFTk is the mean and stan-
dard deviation, respectively, of selected feature k that is extracted from {Wi}i=1:NW
of the training data only.
Principal Component Analysis (PCA) [59] is applied on the normalized features
(nF ) to orthogonally transform them to a lower dimension space with uncorrelated
features. PCA is summarized in the following steps:
1. Finding the covariance matrix (S) of nF that are extracted from the training
data only as follows:
SNF×NF = nF
T
NW×NF · nFNW×NF (3.12)
where nF T is the transpose of nF .
2. Calculating the eigenvalues (λ1×NF ) by solving the characteristic equation:
det(λ1×NF INF×NF − SNF×NF ) = 0 (3.13)
where det is the determinant and I is identity matrix.
3. Calculating the eigenvectors (xNF×NF ) by solving the following system of linear
equations:
xNF×NF (λ1×NF INF×NF − SNF×NF ) = 0 (3.14)
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4. Sorting the eigenvalues descendingly and accordingly sorting the eigenvectors.
5. Accumulating the sorted eigenvalues or energy and saving the eigenvectors that
represent 99% of the features energy (xNF×NxF , where NxF is the number of
saved eigenvectors).
6. Projecting the normalized features that were extracted from all the data on the
xNxF×NF to transform them to the new dimensional space (FNW×NxF ) as follows:
FNW×NxF = nFNW×NF · xNF×NxF (3.15)
3.2.4 Fuzzy Classification
3.2.4.1 Training
Before training SVM model on FNW×NxF extracted from the training data, there is
a need to tune SVM parameters (linear or RBF kernel, the cost parameter (c), and
The gamma parameter (γ) in case RBF kernel is used). Grid search is performed
for this purpose based on n-fold cross-validation on the training dataset. The search
values of c are 2{−6,−4,...,4}, and the search value of γ are 2{−8,−6,...,4}. The folds of
cross-validation are activity-based which requires identifying the activities that the
patients were doing while recording the training dataset and then labeling each feature
vector with specific activity. This method of cross-validation selects the parameters
that make the SVM model generalizing well to new activities. The accuracy of the
SVM model in each trail in the grid search is calculated and the parameters of the
model with highest accuracy are chosen.
If the activities information is not available for the training data or if the SVM
model failed to gain more than 65% accuracy on the activity-based cross-validation,
then assigning each feature vector to the n-folds of cross-validation are performed
randomly. All the parameters’ ranges and steps of grid search, other than feature
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vector’s assignment to folds, remain the same as above. After selecting the opti-
mal parameters, SVM model is trained using them on FNW×NxF extracted from the
training data. After completing training, the calculated W and b that defines the
hyperplane will be used to find the decision values (DV1×NW ) for the training fea-
ture vectors in FNW×NxF . After that, DV1×NW in addition to the ground truth labels
(GT1×NW ) will feed into Platt scaling method to estimate A and B parameters.
3.2.4.2 Testing: Fuzzy labeling
The trained SVM model is used to get a decision value for each feature vector in
FNW×NxF extracted from the testing data. Because of using sliding window of length
5-second and 4-second overlap, each decision value is for five seconds and four of
them are used for the previous and next decision values. Therefore, if each decision
value is repeated for 5 times (one for each second), then each second in the gyroscope
signal will have five decision values as shown in Figure 3.3, except the four seconds
at the beginning and end of the signal. The mean of a vertical window of the five
decision values for each second is performed to get a single value for each second.
This technique will lower the effect of outliers in the shared decision values.
The medication state does not change rapidly (usually it takes 30 minutes to
change from OFF to ON or vice versa), so the adjacent decision values should be
similar. Therefore, the decision values are filtered using sliding 40-second averaging
filter to eliminate the effect of outliers or incorrect decisions. The last step is labeling
the averaged decision values (DV ) > zero as OFF, or as ON if they are < zero to get
the final medication state predications (MD).
3.2.4.3 Testing: Classification Certainty
After providing prediction of the medication state for each second using the gyroscope
signals, the certainty of each prediction is found in this section by applying Platt
36
CHAPTER 3. PROPOSED METHODS
Window # 1 2 3 4 5 6 7 8 9 10 . . . . . . W NW
Decision Values d1 d2 d3 d4 d5 d6 d7 d8 d9 d10 . . . . . . d NW
Repeating and Reshaping
d1 d1 d1 d1 d1
d2 d2 d2 d2 d2
d3 d3 d3 d3 d3
d4 d4 d4 d4 d4
d5 d5 d5 d5 d5
d6 d6 d6 d6 d6
d7 d7 d7 d7 d7
d8 d8 d8 d8 d8
d9 d9 d9 d9 d9
d10 d10 d10 d10 d10
.  .  .  .  . 
d NW d NW d NW d NW d NW
d NW-1 d NW-1 d NW-1 d NW-1 d NW-1
d NW-2 d NW-2 d NW-2 d NW-2 d NW-2
d NW-3 d NW-3 d NW-3 d NW-3 d NW-3
d NW-4 d NW-4 d NW-4 d NW-4 d NW-4
Time (secs) 1 2 3 4 5 6 7 8 9 10 . . . . . . W ND
Decision Values m1 m2 m3 m4 m5 m6 m7 m8 m9 m10 . . . . . . m ND
Averaging Filter_5x1
W 1
W 2
W 3
W 6
W 7
W 8
W NW-4
W NW-3
W NW-2
Mean
Averaging Filter_1x40
Time (secs) 1 2 3 4 5 6 7 8 9 10 . . . . . . W ND
Decision Values m1 m2 m3 m4 m5 m6 m7 m8 m9 m10 . . . . . . m ND
Time (secs) 1 2 3 4 5 6 7 8 9 10 . . . . . . W ND
Medication State 
(OFF, ON)
M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 . . . . . . M ND
Classification Certainty
(0-1)
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 . . . . . . P ND
Platt Scaling
Decision Values > 0
OFF
ON
Window # 1 2 3 4 5 6 7 8 9 10 . . . . . . W NW
Feature Vectors F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 . . . . . . F NW
Trained Classifier
Figure 3.3: After obtaining the decision values from trained classifier for each feature
vector, this figure shows the fuzzy labeling approach proposed in this thesis, and certainty
calculation.
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scaling. Logistic transformation is applied to find the classification certainty (P ) for
the averaged decision values that give OFF or ON predictions using the following two
equations, respectively:
{P (MD = OFF |s)}{s=1:ND|DV (s)>0} =
1
1 + eA×DV (s)+B
(3.16)
where ND is signal length in seconds, and A and B are Platt scaling parameters.
{P (MD = ON |s)}{s=1:ND|DV (s)<0} = 1−
1
1 + eA×DV (s)+B
(3.17)
3.3 Semi-supervised Classification: k-means
One of the problems that can face training SVM model is overfitting the training
data especially if the training data is relatively small with high number of features.
Therefore, semi-supervised classification method using k-means is proposed. In ad-
dition, analysis of the obtained clusters from this method is possible to check if the
feature vectors located in them are related to the PD symptoms or the activities the
patients were doing during data recording. This method is based on semi-supervised
classification with fuzzy labeling proposed by [60].
Segmenting the recorded signals, extracting the PD symptoms-related features,
and applying dimensionality reduction on them are performed in the same way as in
the supervised classification method using SVM (refer to Sections 3.2.1, 3.2.2, and
3.2.3).
3.3.1 Fuzzy Classification
3.3.1.1 Training
Training in this method follows the steps:
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1. Choosing the number of clusters (K) is important to prevent k-means from
underfitting or overfitting the FNW×NxF extracted from the training dataset.
Therefore, optimalK is selected based on grid search using n-fold cross-validation
on the training dataset. The search values of K are {2,3,...,30}. The folds of
cross-validation are either activity-based or random assignments-based as de-
scribed before in Section 3.2.4.1.
2. Using the optimal number of clusters (K) from the previous step, k-means is
used to cluster FNW×NxF extracted from the training dataset. After completing
clustering, the K centroids (~CK×NxF ) are finalized.
3. Each feature vector ( ~fv1×NxF = Fi) is assigned to the closest cluster (CC ~fv)
based on the minimum Euclidean distance to each ~Ck to form cluster per ~fv
array (C ~fv1×NW
) :
{C ~fv(i)}i=1:NW = CC ~fvi = arg
K
min
k=1
‖ ~fvi − ~Ck‖ (3.18)
where ~fvi = Fi.
4. Local membership matrix (LMKX2) is the percentage of ~fv’s being labeled as
OFF (LM(1)KX1) or ON (LM(2)KX1) in each cluster, and is calculated in the
same way in [60] using the following equation:
{LM(m)k}m={1,2},k={1:K} = k(m)
NCkW
(3.19)
where k(m) is the number of ~fv’s that belong to medication state m (1=OFF
or 2=ON) in cluster k, and NCkW is the number of ~fv’s in cluster k (Ck).
5. Global membership matrix (GMKX2) is the percentage of ~fv’s being labeled as
OFF (GM(1)KX1) or ON (GM(2)KX1) in each cluster to the total number of
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ON or OFF ~fv’s in the training data, respectively. It is calculated using the
following equation:
{GM(m)k}m={1,2},k={1:K} = k(m)
NmW
(3.20)
where NmW is the number of ~fv’s being labeled as m in the ground truth of the
training data (GT1×NW ).
6. The strength factor for each cluster (SF1×K) is a measure of how significant each
cluster in discriminating between ON and OFF medication state. It calculated
by using the following equation:
{SF (k)}k=1:K = (LM(1)k ×GM(1)k)− (LM(2)k ×GM(2)k) (3.21)
The construction of this factor using local and global memberships of each
cluster is a novel approach that is used in this thesis. The idea is to give low
weights for the clusters with few number of ~fv’s while performing labeling on
testing data. These clusters contain feature vectors that are mainly outliers. In
addition, it preserves the ability to give low weights for the common clusters
that contain ~fv’s that represents both medication states, and high weights for
the clusters that mainly contain OFF or ON ~fv’s. The range of this factor is
(-1,1). (SF > zero) is for clusters that represent OFF state and higher SF
means the cluster is better in representing the OFF state. (SF < zero) is for
clusters that represent ON state and lower SF means the cluster is better in
representing the ON state.
7. The final step is estimating the parameters (A and B) of Platt scaling. This is
done by first finding the decision values for all ~fv’s (DV1×NW ) by assigning SF
to each cluster number in C ~fv1×NW
as in the equation below, and second feeding
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DV1×NW and GT1×NW to Platt scaling method.
{DV (i)}i=1:NW = SF (C ~fv(i)) (3.22)
An example of the training results in shown in Figure 3.4. This figure shows a
sample of the clustered ~fv’s from the training data of dataset1 using three features,
the clusters and the medication states on top on them using different colors and
notations. In addition, it relates some of the clusters to their centroids and strength
factors.
3.3.1.2 Testing
Training the semi-supervised classifier results in K centroids (~CK×NxF ), strength factor
for each cluster (SF1×K), and Platt scaling parameters (A and B). These saved
parameters are used in the testing procedure following the steps:
1. Each feature vector in FNW×NxF extracted from the testing data is assigned to
the closest cluster (CC ~fv) based on the minimum Euclidean distance to each
~Ck to form cluster per ~fv array (C ~fv1×NW
) using Equation 3.18.
2. Each cluster number in C ~fv1×NW
is assigned the corresponding value from SF1×K
to find the decision values for all ~fv’s (DV1×NW ) using Equation 3.22.
3. The same procedure for fuzzy labeling and classification certainty described in
Section 3.2.4.2, and Section 3.2.4.3 are used to complete this method.
3.4 Semi-supervised Classification: SOTM
One of the limitations of using K-means for semi-supervised classification is pre-
defining the number of clusters (K) before starting clustering. The solution that we
proposed before in Section 3.3.1.1 is time and computational power consuming if it
41
CHAPTER 3. PROPOSED METHODS
Cluster 
Number
Centroids Strength 
FactorF1 . . . . . F NxF
1 -0.242 . . . . . 2.362 0.1
2 -0.13 . . . . . 1.960 0.6
3 -0.679 . . . . . 1.698 0.05
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
K -0.377 . . . . . 2.4392 -0.5
F
ea
tu
re
 3
Figure 3.4: An example of the results of training in semi-supervised classification using
k-means. The top part shows the feature vectors using three features and the bottom part
relates them to their centroids and strength factors.
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used for large training dataset. Therefore, SOTM (refer to Section 2.2.2.2 for details)
is used in the semi-supervised classification instead of k-means in this method be-
cause no need to predefine K. SOTM algorithm determines K value based on the
data distribution and the predefined resolution of clustering.
The same procedure that is described in semi-supervised classification using k-
means (Section 3.3) is used in this method except the first and second steps in the
training section 3.3.1.1. The two steps are changed as follow:
1. Setting clustering resolution using SOTM is important to prevent it from over-
fitting the FNW×NxF extracted from the training dataset. Therefore, grid search
is performed using n-fold cross-validation on the training dataset. It searched
the following values of H(∞): (10%, 20%,..., 90%) of the maximum standard
deviation of features in FNW×NxF . H(∞) represents the minimum value of H(r)
and prevents the SOTM from overfitting the training data. The folds of cross-
validation are either activity-based or random assignments-based as described
before in Section 3.2.4.1.
2. Using the minimum value of the hierarchical control function (H(∞)) from
the previous step, SOTM is used for clustering FNW×NxF extracted from the
training dataset. After completing clustering, the K centroids (~CK×NxF ) and
The strength factors (SF1×K) are finalized and can be used for testing.
3.5 Supervised Classification: LSTM
Nowadays, architectures that are based on deep learning including recurrent neural
networks proven to be effective and secure the state of the art in different application.
From the applications that based on data recorded using inertial sensor are medica-
tion state assessment [31], the detection of bradykinesia [19], and activity recogni-
tion [61, 62]. However, deep learning is not fully investigated in the applications of
43
CHAPTER 3. PROPOSED METHODS
detecting and assessing PD symptoms and states, and to the best of our knowledge,
LSTM network was not used before to discriminate between the medication states.
Therefore, deep learning represented by LSTM architecture is implemented in this
method to explore the possibility of assess the medication states given that there are a
temporal dependencies between PD symptoms and the medications states in general.
Before feeding the signals of the inertial sensors to the LSTM network, two types
of segmentation is experimented which are 5-second windows with 4-second overlap
as described in Section 3.2.1 or 1-second window without overlap. Constructing the
mini-batch follows the method presented by [61]. In this method, NB points on the
training signal (where NB is the number of segments in each mini-batch) is randomly
generated to represent the beginning of each segment in the mini-batch. Each of the
segments will slide starting from its point toward the end of the signal by 1 second
shift with each iteration. If one of the segments reached the end of the signal, then
training LSTM model in this epoch will stop and new epoch will start with new NB
points initialization. This method preserves the temporal dependencies between the
signal samples and prevents the model from being biased toward one class.
LSTM model that is large enough may memorize the training signal especially if
the training dataset is small that lead to overfitting and low medication state assess-
ment on the testing data. Therefore, the internal states of LSTM after training on
each mini-batch is passed over to the next training iteration with a carry-over proba-
bility [61], and they are zeroed out otherwise. The other method that is proposed in
this thesis is applying the carry-over probability on both internal and hidden sates.
These two methods are applied to prevent the LSTM from memorizing the training
signals implicitly.
The LSTM cell proposed in [1] is used in this method without using peephole
connections. Figure 3.5 shows the different components of many to one output LSTM
architecture that is applied in this thesis. Each window of the gyroscope signals is first
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linearly transformed to have a depth equal to the number of hidden states in LSTM
layer. Second, the transformed signal is passed through LSTM network sample per
sample. Finally, the hidden state for the last sample in each window is pass through
a fully connected layer of size (#units or hidden states, 2) and a soft-max layer to
obtain a probability for each medication state (Classification Certainty (P )) that is
used to predict the medication state (OFF or ON). The pseudo-code 1 shows these
steps in more details. The weighs of the fully connected layers are initialized using
random values from normal distribution of zero mean and 0.1 standard deviation,
whereas the biases are initialized to the constant value (0.1).
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y
k
. . . .
W (L)
1 X n Channelsk
X  (L)
1 X m Statesk
. . . .
W (2)
1 X n Channelsk
X  (2)
1 X m Statesk
Fully Connected Layer
Soft-max layer
LSTM Cell
LSTM Cell
LSTM Cell
LSTM Cell
Internal States
Hidden States
W (1)
1 X n Channelsk
X  (1)
1 X m Statesk
LSTM Cell
LSTM Cell
Figure 3.5: Many to one architecture of LSTM. LSTM network is unfolded in time for
forward computations of a window (Wk) at kth second. Each sample that has depth of
n channels is linearly transformed to have a depth of m hidden states. The hidden states
from last layer after passing the last sample (WK(L)) is passed through fully connected and
soft-max layers to assess the medication state for each window. Vertical dotted-blue lines
represent a drop-out on the hidden states between the layers. Horizontal continuous-blue
and continuous-black lines represent the hidden and internal states that flow through time,
respectively.
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Pseudo-code 1 Training and testing LSTM network with m hidden states using
n-channel gyroscope signal.
1: Initialize hyper-parameters to build and train LSTM network
2: Build the LSTM network
3: Load the dataset
4: # Subject-based leave-one-out cross-validation
5: Divide the dataset into k_fold # k=number of patients
6: for Pn← 1, k_fold do
7: # Training LSTM model on all folds except fold #Pn
8: for Ei← 1, max number of epochs do
9: Select NB seconds randomly on the training signal
10: Create NB segments that start from the NB seconds
11: Initialize the hidden and internal states of LSTM network with zeros
12: while no segment reached the end of the signal do
13: Construct a mini-batch of size NB from the segments
14: # training LSTM network using the mini-batch
15: for s← 1, last sample in the segments of mini-batch do
16: Linearly transform the samples s to a depth of m instead of n
17: Perform forward propagation on LSTM using the samples s
18: Linearly transform the hidden states of last sample to a depth of 2
19: Compute the loss using softmax cross entropy
20: Perform L2-norm regularization and find mean loss of the mini-batch
21: Perform back-propogation through time using an optimizer
22: # Finding and saving the training loss and the model from epoch Ei
23: for g ← 1, last segment in the signal do
24: for s← 1, last sample in the segment g do
25: Linearly transform the sample s to a depth of m instead of n
26: Perform forward propagation on LSTM using the sample s
27: Linearly transform the hidden states of last sample to a depth of 2
28: Compute the loss of segment g using softmax cross entropy
29: Compute the average training loss
30: # Selecting and testing LSTM model on fold #Pn to find testing loss and
31: # other performance metrics
32: Select the trained model with lowest training loss
33: for g ← 1, last segment in the signal do
34: for s← 1, last sample in the segment g do
35: Linearly transform the sample s to a depth of m instead of n
36: Perform forward propagation on LSTM using the sample s
37: Linearly transform the hidden states of last sample to a depth of 2
38: Pass them through a soft-max layer
39: Find the medication state for segment g
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Results and Discussions
This chapter starts by explaining the parameters that were used to evaluate the
proposed methods. Next, it reports the evaluation results of the developed methods
on the two datasets that included recordings of 19 PD patients. Two scenarios were
considered: general training/classification and patient-specific where the former trains
and tests the algorithm using subject-based leave-one-out cross-validation for each of
the datasets, and the latter trains and tests the algorithm for each patient individually.
In patient-specific scenario, data that were recorded while patients were perform-
ing four activities in ON and OFF states was used to train a classifier for each pa-
tient, whereas, the rest of the data for the same patient were used for testing. These
activities are ambulation, drinking, arm resting and dressing that are used in the
routine clinical settings for rating dyskinesia severity in Unified Dyskinesia Rating
Scale (UDysRS) and Core Assessment Program for Surgical Interventional Therapies
in Parkinson’s disease (CAPSIT-PD). Hence, collecting the required data for training
patient-specific classifier will be through the existing PD clinical settings and will not
enforce additional burden to patients or clinicians. In addition, for patient-specific
scenarios, a new method is proposed to select the number and placement of sensors
for each patient.
The results of supervised classification using SVM and LSTM in the first scenario
are presented first, and they are compared with the results of patient-specific super-
vised and semi-supervised approach which reported next. After that, the method with
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the highest results is compared with other studies. Lastly, this chapter presents the
results of feature analysis to show the advantage of using the directional information
in X, Y, and Z axes vs. their magnitude.
4.1 Performance metrics
Three metrics were used to evaluate the trained classifiers to detect the two medication
states which are accuracy, sensitivity and specificity of the OFF state. The accuracy
is the percentage of correct medication state predictions that classify each second in
the recorded signals. Sensitivity of the OFF state is the percentage of correct OFF
medication state predications that classify each second in the recorded data during
the OFF state. Specificity of the OFF state is the percentage of correct ON state
predications that classify each second in the recorded data during the ON state.
4.2 Generally-trained Classifiers
4.2.1 Supervised Classification: SVM
Supervised classification method using SVM (refer to section 3.2) was trained and
validated using subject-based leave-one-out cross-validation. Equal amount of data
for each state for each patient selected in the training folds was used for training
and all the data for each patient selected in the validation folds was used for testing.
Using equal number of windows for each state prevents the SVM model from being
bias toward one of the states. Training and validation were performed separately
dataset 1 and 2. LibSVM library [63] was used to train and test the SVM classifier.
For dataset 1, if only one round of activities was recorded in the OFF state for a
patient, then it was used with one round of ON state for training, else all the rounds
were used for training for the patients selected in the training folds. This dataset
contains twelve patients, so 12-fold cross-validation was used. The eleven folds that
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were used for training each time had roughly 1.5 hours of recorded data that split
equally between the two states. The fold that was used for testing in each time had
about 15 minutes of recorded data.
For dataset 2, equal amount of recorded data that represents ON and OFF states
are used for training from each patient selected in the training folds. This dataset
contains seven patients, so 7-fold cross-validation was used. The six folds that were
used for training each time had roughly 5.5 hours of recorded data that split equally
between the two states. The fold that was used for testing in each time had about
two hours.
The data recoded using each of the sensors and a combination of the sensors
were used to train and validate the SVM classifier to experiment the effect of the
sensors placement on detecting the ON and OFF state for each patient and for all
of them. Three sensors from the first and second datasets were experimented which
were (wrist, trunk and ankle) and (wrist, thigh and ankle), respectively. Table 4.1
and 4.2 shows the average testing accuracy, sensitivity and specificity for the first
and second datasets, respectively. Medication state detection using data recorded
using sensor mounted on the ankle outperformed the detection that was based on
data recorded using wrist, trunk, or thigh sensors. Using two sensors increased the
accuracy for both first and second dataset, and using the ankle with trunk or with
thigh resulted in the highest accuracies which were 71.64 for the first dataset and
78.48 for the second dataset. Using three sensors together reduced the accuracy and
specificity and increased the sensitivity.
As a result, using two sensors mounted on ankle and trunk or ankle and thigh
had the highest accuracy in general. However, generalizing the same number and
placement of sensors was not the case for all the patients. Figure 4.1 and 4.2 shows
the results for each the patients for the first and second datasets, receptively. For
instance in dataset 1 as shown in Figure 4.1 , the highest accuracy that was obtained
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Table 4.1: Average testing results of SVM model that was generally training using patient-
based leave-one-out cross-validation (12 folds) on dataset 1. The results are the accuracy,
sensitivity and specificity for multiple experiments using single or a combination of sensors.
Sensors Used Accuracy Sensitivity Specificity
Wrist 65.65 72.26 63.41
Trunk 65.85 63.75 67.09
Ankle 67.37 66.9 68.17
Wrist and trunk 71.44 76.71 69.17
Wrist and ankle 68.67 72.59 67.86
Trunk and ankle 71.64 70.97 72.72
Wrist, trunk
and ankle
71.59 77.79 68.74
Table 4.2: Average testing results of SVM model that was generally training using patient-
based leave-one-out cross-validation (7 folds) on dataset 2. The results are the accuracy,
sensitivity and specificity for multiple experiments using single or a combination of sensors.
Sensors Used Accuracy Sensitivity Specificity
Wrist 64.94 62.69 70.64
Thigh 74.18 72.78 73.03
Ankle 77.27 75.99 72.66
Wrist and thigh 74.05 70.82 79.9
Wrist and ankle 77.22 75.34 79.45
Thigh and ankle 78.48 78.13 74.26
Wrist, thigh
and ankle
77.61 86.61 48.92
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for patient 1, 3 and 7 was for the wrist and trunk sensor, and for patient 2, 4, and
9 was for the ankle sensor. In addition, OFF sensitivity changed significantly if the
sensor that was used to training the SVM model was changed as shown for patient 2,
4, 7 and 9 in 4.1 and patient 1, 4 and 5 in Figure 4.2. Therefore, there is a need to
train a patient-specific classifier to cope with this variability between patients.
4.2.2 Supervised Classification: LSTM
Supervised classifier using LSTM network was trained and validated using subject-
based leave-one-out cross-validation. Datasets were divided for training and testing
data in the same way described before in the previous Section 4.2.1. TensorFlow [64]
was used to implement, train and test the LSTM network proposed in this thesis.
LSTM networks were trained for 300 epochs and the calculated training loss and
trained weights were saved after each epoch. Because both datasets are relatively
small, no validation set was used to select the best model for testing. Instead, the
model with the lowest loss on the training data was selected and validated on the
testing folds.
Table 4.3 contains the LSTM hyper-parameters that were examined. They were
mainly explored on data recorded using the ankle sensor which was shown in the previ-
ous section to provide the highest accuracy if only one sensor was used. In addition,
three types of optimizers are tested which are: adagrad [65], momentum [66], and
adam [67]. The following parameters were shown to yield the highest accuracy with
adam optimizer: 64 hidden states of two LSTM layers, truncated back-propagation
length = one second, learning rate = 0.001, min-batch size = 128, out-keep proba-
bility = 0.5, carry-out probability = 1. The learning rate and out-keep probability
had the highest effect on the LSTM performance. Using carry-out probability lower
than 1 on the internal states didn’t help improving the results. In addition, applying
carry-over probability on both internal and hidden sates reduced the oscillation in the
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Figure 4.1: Testing results of SVM model that was generally training using patient-based
leave-one-out cross-validation (12 folds) on dataset 1. The results are the accuracy, sensi-
tivity and specificity for multiple experiments using single or a combination of sensors for
each of the patients or the folds.
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Figure 4.2: Testing results of SVM model that was generally training using patient-based
leave-one-out cross-validation (7 folds) on dataset 2. The results are the accuracy, sensitivity
and specificity for multiple experiments using single or a combination of sensors for each of
the patients or the folds.
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Table 4.3: The LSTM Hyper-parameters that were explored in this thesis
# of Layers 1, and 2 # Units
32, 64,
128, and 256
Truncated Back-propagation
Length (sec)
1, and 5 Learning Rate
0.1, 0.025,
0.01, and 0.001
Batch Size
32, 64,
128, and 256
Out-keep
Probability
1, 0.7, and 0.5
Carry-over Probability
1, 0.7,
and 0.5
# Sensor Used
Ankle, and
(ankle and trunk)
training and testing losses, but at the same time reduced the testing accuracy signif-
icantly. Therefore, using carry-over probability less than 1 prevented LSTM model
from memorizing long sequences precisely, but at the same time the LSTM was less
dependent on patterns flow more than one second in the signal. In other word, this
method was forcing the model to learn from each window, so the internal and hidden
states of LSTM from the previous window will have small or no effects. To check this
behavior, the internal and hidden states was initialized to zero after each mini-batch
training and the results were similar to using carry-over probability=0.5. The trained
networks did not suffer from exploding gradient, so gradient clipping technique was
not applied.
The results of LSTM network are shown in Table 4.4 using data recorded using
only ankle sensor or both trunk and ankle in dataset 1. The accuracy of LSTM model
using only ankle sensor outperformed SVM classifier accuracy for this sensor by 5%.
However, the LSTM network was overfitting the training data very quickly using two
sensors which made it poorly generalize to the testing data. The reason for overfitting
was adding new channels to relatively small training data.
For the second dataset, the results of the LSTM network are shown in Table 4.5
using data recorded using only ankle sensor. Only ankle senor was used because it was
shown to have the highest performance and also using two sensors for small dataset
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Table 4.4: Average testing results of LSTMmodel that was generally training using patient-
based leave-one-out cross-validation (12 folds) on dataset 1. The results are the accuracy,
sensitivity and specificity using the ankle or a combination of trunk and ankle sensors.
Ankle Trunk and ankle
Patient # Acc. Sens. Spec. Acc. Sens. Spec.
1 89.14 88.77 89.30 89.95 81.81 93.48
2 82.34 62.2 89.24 68.99 61.04 71.71
3 60.57 67.56 58.21 46.65 94.59 30.47
4 93.85 93.98 93.81 88.85 93.44 87.23
5 80.15 86.52 78.01 69.06 59.06 72.42
6 75.33 24.55 92.36 42.85 76.64 31.52
7 75.33 56.52 93.9 74.62 70.65 78.67
8 54.14 29.91 78.51 50 28.49 71.63
9 80.79 51.47 90.71 69.26 88.72 62.68
10 61.94 71.12 58.59 62.94 87.7 53.9
11 56.53 80.58 30.76 64.51 93.35 33.61
12 64.46 47.11 84.85 62.78 49.33 78.59
Average 72.86 63.36 78.19 65.87 73.73 63.83
will lead to overfitting. LSTM for dataset 2 yielded approximately the same accuracy
and sensitivity for SVM, but it outperformed SVM specificity by about 10%.
To sum up, when only one sensor mounted on the ankle was used for general
training and testing, the algorithm based on LSTM performed better than SVM with
74.91%, 69.42%, and 80.55% for accuracy, sensitivity, and specificity, respectively,
whereas, SVM yielded 72.32% accuracy, 71.44% sensitivity, and 70.41% specificity.
4.3 Patient-specific Classifiers
Three methods which are supervised classification using SVM (refer to Section 3.2)
and semi-supervised using k-means or SOTM (refer to Section 3.3 and 3.4) were
trained for each patient specifically. Data that were recorded while patients were
performing four activities in ON and OFF states were used to train a classifier for
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Table 4.5: Average testing results of LSTMmodel that was generally training using patient-
based leave-one-out cross-validation (7 folds) on dataset 2. The results are the accuracy,
sensitivity and specificity using the ankle sensor.
Patient # Acc. Sens. Spec.
1 87.27 84.03 100
2 86.686 99.4 60.74
3 80.84 79.91 100
4 91.56 88.54 100
5 74.78 63.55 97.35
6 71.23 81.84 41.07
7 46.37 31.02 81.17
Average 76.96 75.47 82.9
each patient. These activities are ambulation, drinking, arm resting and dressing.
For dataset 1, the four activities were selected from two round, one for each
medication state, and were used to train the classifier for each patient individually,
whereas, the rest of the data from the same patient were used for testing. Total
time of the recorded data that was used for training and testing for each patient was
roughly four and ten minutes, respectively.
Despite the small amount of data used for training the patient-specific classifier
(about 250 feature vectors), supervised classification using SVM obtained higher ac-
curacy and sensitivity using single or a combination of sensors for each of the patients
as shown in Figure 4.3. However, SVM resulted in classification specificity that is ap-
proximately equal to the results of other two methods, or a little bit lower especially if
the trunk sensor was used. The second high performance was for the semi-supervised
using SOTM that achieved a little bit higher accuracy than using k-means for the
semi-supervised classification.
Figure 4.4 shows the results of patient-specific classification using SVM for each
patient using single or a combination of sensors. SVM was used because it yielded
the highest accuracy as compared before in Figure 4.3. It is clear that specific sensor
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Figure 4.3: The average classification accuracy, sensitivity and specificity of the testing
data using single or a combination of sensors for each of the patients after training patient-
specific models on features extracted from X, Y, and Z signals. The classification models
are semi-supervised using k-means or SOTM and supervised using SVM.
58
CHAPTER 4. RESULTS AND DISCUSSIONS
placement for each patient plays vital role in medication state prediction with high
accuracy. For instance, ankle sensor for patient 12 yielded 96% accuracy while the
second highest accuracy was 80% for the trunk sensor. For patient 10, the trunk gave
the highest accuracy while for patient 5, a combination of the ankle and trunk had
the highest accuracy.
Inspecting UPDRS score for each patient and comparing it with the results in
Figure 4.4 showed that for patient with average change in UPDRS score between OFF
and ON states more than 20, one sensor mounted on the limb with highest change in
tremor score is sufficient to obtain high classification accuracy. An exception for this
case is if the patient shows approximately equal rest tremor on the face, upper and
lower extremities, then two sensors mounted on ankle and trunk or wrist (if trunk
sensor was not used) are preferred. Examples of this case were patient 1 and 12,
while patient 9 was an example for the exception. For patient with average change
in UPDRS score between OFF and ON states more than 10 and lower than 20, two
sensors mounted on upper body (trunk) and lower body (ankle) are sufficient to
obtain high classification accuracy. Examples for this case were patient 4, 5, 7, 10
and 11. For other patients with change in UPDRS lower than 10, using three sensors
are preferred to get consistent results and to prevent the model from being bias to
one of the states.
Based on the correlation between the average change in UPDRS score between
OFF and ON state for each patient and the presence of rest tremor, selecting the
number of sensors and their placement for each patient was proposed as shown in
Table 4.6. The low accuracy for patient 3, 6, 8 and 11 was because they had low
benefit from their medication as it is clear from their change in UPDRS score which
were 4.7, 6.7, 6.5 and 14.5, respectively. In addition, having dyskinesia during OFF
state was another reason for low performance for Patients 6 and 8, whereas, patient
3 showed higher tremor in one of the ON rounds than OFF rounds. The data used
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for training the model for patient 11 did not include tremor, whereas, this symptom
presented in testing data and it was the main reason for misclassification for this
patient. An example of the report generated by patient-specific SVM classifier is
shown in Figure 4.5 for patient 12 using the data recorded using ankle sensor. This
figure also shows the classification certainty for each second and it was low for the
transition between the two states and for activity 5 and 8 that were misclassified in
round 3.
The proposed method for selecting the number and placement of the sensors was
validated on the second dataset. After annotating the activities that the patient were
doing in dataset 2, the same four activities used before were selected for the two
medication states and were used to train the classifier for each patient individually,
whereas, the rest of the data from the same patient were used for testing. Each of
the selected activities was about two minutes. Total time of the recorded data that
was used for training and testing for each patient was roughly 15 and 105 minutes,
respectively.
Table 4.7 shows the detection results for dataset 2 based on the proposed selec-
tion of the number of sensors and their placement for each patient. Because sensor
mounted on trunk was not used in dataset 2, thus wrist sensor was used instead if
required. Patients 1 and 4 showed average change in UPDRS score > 20 and rela-
tively high wrist tremor, thus the sensor mounted on the wrist was used for them
instead of ankle sensor. Patient 7 showed average change in UPDRS score > 20 with
face, wrist and leg tremor, thus sensors mounted on wrist and ankle were used for
this patient. For other patients, the same proposed method for dataset 1 was used.
The highest accuracy was associated with patients who showed change in UPDRS >
20, and the lowest accuracy was for patients 2 and 6 who showed low improvement in
their UPDRS score after medication in addition to having tremor score in ON state
that was higher or equal to tremor score in the OFF state.
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Figure 4.4: Testing results of patient-specific SVM model for each of the patient in dataset
1. The results are the accuracy, sensitivity and specificity for multiple experiments using
single or a combination of sensors.
61
CHAPTER 4. RESULTS AND DISCUSSIONS
Table 4.6: Average testing results of patient-specific SVM model for dataset 1. The results
are the accuracy, sensitivity and specificity using single or a combination of sensors based
on the average change in UPDRS score between OFF and ON state for each patient and
the presence of rest tremor.
Patient # Acc. Sens. Spec. Sensor used
Average Change
in UPDRS Score
between OFF
and ON
1 99.22 100 99 Ankle 22.7
2 63.26 87.78 58.73
Wrist, trunk
and ankle
9
3 43 100 33.06
Wrist, trunk
and ankle
4.7
4 98.64 100 98.39
Trunk and
ankle
15
5 95.89 90.67 96.77
Trunk and
ankle
12
6 41.18 80 34.02
Wrist, trunk
and ankle
6.7
7 82.54 70.16 95.03
Trunk and
ankle
15
8 64.38 51.17 77.76
Wrist, trunk
and ankle
6.5
9 94.28 85.62 95.66
Trunk and
ankle
24
10 85.47 40 93.85
Trunk and
ankle
13.7
11 63.86 99.68 27.92
Trunk and
ankle
14.5
12 95.45 91.28 100 Ankle 22
Average 77.26 83.03 75.84
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Figure 4.5: The classification results (1 OFF, 2 ON) with the certainty (continuous red
line between 0 and 1) for each round for patient 12 using patient-specific SVM trained and
testing on data recorded using ankle sensor in dataset 1. The activities are 1=ambulation,
2=arms resting, 3=cutting, 4=dressing, 5=drinking, 6=unpacking groceries, 7=hair brush
with left hand, and 8=hair brush with right hand.
To inspect if the selection of sensors was optimal for each patient in dataset 2,
patient-specific SVM classifier was trained and tested on all possible combination of
wrist, thigh and trunk sensors. The results for this experiment are shown in Figure
4.6. For all the patients, the selected sensors yielded the highest accuracy except for
patients 3 and 5, but the difference was not significant.
4.4 Patient-specific vs. Generally-trained Classifiers
To compare the results of generally-trained SVM classifier with patient-specific SVM
classifier, the highest results of using generally-trained SVM in Tables 4.1 and 4.2
are used which was based on using trunk and ankle sensors for dataset 1 and using
thigh and ankle sensors for dataset 2. In addition, highest results of generally-trained
LSTM network are used for the comparison. The comparisons are shown in Tables
4.8 and 4.9 for the first and second datasets, respectively.
Patient-specific SVM outperformed generally-trained SVM and LSTM by about
5% accuracy for both datasets. For the first dataset, the results of the three methods
were correlated for most patient. However, for some patients, the results were signifi-
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Table 4.7: Average testing results of patient-specific SVM model for dataset 2. The results
are the accuracy, sensitivity and specificity using single or a combination of sensors based
on the average change in UPDRS score between OFF and ON state for each patient and
the presence of rest tremor.
Patient # Acc. Sens. Spec. Sensor used
Average Change
in UPDRS Score
between OFF
and ON
1 96.64 97.93 90.3 Wrist 23
2 64.37 61.52 71.31
Wrist, thigh
and ankle
3
3 79.38 80.12 52.13
Wrist, thigh
and ankle
3
4 99.43 99.26 100 Wrist 34
5 78.18 79.1 76.2
Wrist and
ankle
13
6 63.94 59.02 81.58
Wrist and
ankle
10
7 92.68 91.24 96.26
Wrist and
ankle
22
Average 82.09 81.17 81.11
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Figure 4.6: Testing results of patient-specific SVM model for each of the patient in dataset
2. The results are the accuracy, sensitivity and specificity for multiple experiments using
single or a combination of sensors.
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Table 4.8: Average testing results of patient-specific SVM model vs. generally trained SVM
and LSTM models for dataset 1. Training patient-specific SVM used single or a combination
of sensors based on the average change in UPDRS score between OFF and ON state and
the presence of rest tremor for each patient, whereas, training generally-trained SVM and
LSTM used two sensor mounted on trunk and ankle, and only one sensor mounted on the
ankle, respectively.
Patient-specific
SVM
Generally-trained
SVM
Generally-trained
LSTM
Patient # Acc. Sens. Spec. Acc. Sens. Spec. Acc. Sens. Spec.
1 99.22 100 99 92.32 94.52 91.37 89.14 88.77 89.30
2 63.26 87.78 58.73 63.97 38.73 72.58 82.34 62.2 89.24
3 43 100 33.06 49.83 82.03 38.98 60.57 67.56 58.21
4 98.64 100 98.39 98.91 100 98.53 93.85 93.98 93.81
5 95.89 90.67 96.77 88.7 64.44 96.86 80.15 86.52 78.01
6 41.18 80 34.02 60.78 50.75 64.14 75.33 24.55 92.36
7 82.54 70.16 95.03 88.21 84.03 92.47 75.33 56.52 93.9
8 64.38 51.17 77.76 43.41 49.64 37.16 54.14 29.91 78.51
9 94.28 85.62 95.66 42.57 81.78 29.33 80.79 51.47 90.71
10 85.47 40 93.85 92.62 79.91 97.2 61.94 71.12 58.59
11 63.86 99.68 27.92 71.11 83.41 58.07 56.53 80.58 30.76
12 95.45 91.28 100 67.19 42.41 95.94 64.46 47.11 84.85
Average 77.26 83.03 75.84 71.64 70.97 72.72 72.86 63.36 78.19
cant using specific method. The significant results were for patient 2, 9, 10 and 12 in
dataset 1 (as shown in bold font in Table 4.8). Patient-specific SVM yielded very high
accuracy that is more than 90% for patient 12, whereas generally-trained SVM and
LSTM classifiers poorly performed. For patient 2, LSTM network yielded the highest
accuracy. For patient 9, patient specific SVM and LSTM performed much better than
generally-trained SVM. For patient 10, SVM performed better than LSTM.
For the second dataset, the same correlated pattern between the methods results
occurred. However, LSTM performed very well for patient 2, but it performed poorly
on patient 7. In addition, for patients in dataset 2 with average change in UPDRS
> 20, generally-trained SVM classifier did not exceed 89% accuracy whereas Patient-
specific SVM yielded accuracy > 92% (as shown in bold font in Table 4.9). The
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Table 4.9: Average testing results of patient-specific SVM model vs. generally trained SVM
and LSTM models for dataset 2. Training patient-specific SVM used single or a combination
of sensors based on the average change in UPDRS score between OFF and ON state and
the presence of rest tremor for each patient, whereas, training generally-trained SVM and
LSTM used two sensor mounted on thigh and ankle, and only one sensor mounted on the
ankle, respectively.
Patient-specific
SVM
Generally-trained
SVM
Generally-trained
LSTM
Patient # Acc. Sens. Spec. Acc. Sens. Spec. Acc. Sens. Spec.
1 96.64 97.93 90.3 88.52 88.68 87.89 87.27 84.03 100
2 64.37 61.52 71.31 62.92 54.4 80.28 86.686 99.4 60.74
3 79.38 80.12 52.13 82.32 84.1 45.71 80.84 79.91 100
4 99.43 99.26 100 87.34 83.1 99.21 91.56 88.54 100
5 78.18 79.1 76.2 83.64 80.59 89.76 74.78 63.55 97.35
6 63.94 59.02 81.58 58.09 61.02 49.79 71.23 81.84 41.07
7 92.68 91.24 96.26 86.49 95.01 67.18 46.37 31.02 81.17
Average 82.09 81.17 81.11 78.48 78.13 74.26 76.96 75.47 82.9
reason behind poor performance of generally-trained SVM for some of the patients is
the significant variability between PD subjects as mentioned before in the introduction
of this thesis and as will be explained at the end of this section.
LSTM network for both datasets yielded the highest specificity of the OFF state.
In addition, it outperformed patient-specific and generally-trained SVM for some
patients using only one sensor. This shows its adaptation ability to new patient
to cope with the variability between patients if more data were recorded for more
patients and used for training.
Feature analysis was performed on the extracted features from X, Y and Z signals
for all the patients in dataset 1 to illustrate the variability between patients on feature
selection. These signals were used before to train the patient-specific classifiers (refer
to Section 4.3). Feature selection was performed based on the statistical analysis
proposed in Section 3.2.3.1 on the features extracted from the three axes of sensors
mounted on wrist, trunk and ankle. Significant features were the features with p-value
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from the statistical analysis < 0.05. To inspect the effect of the variability between
patients on feature selection, the percentage of occurrence of the significant features
for at least one of the three axes of each sensor to the total number of patients was
determined as shown in Figure 4.7. The features were not selected uniformly for all
the patient, for instance, features number 1, 11, 16, 18, 23, 24 and 25 were selected for
one of the sensors of less than 70% of the patients. Therefore, nonuniform occurrence
of the significant features is an indication of the variability between patients. In
addition, selecting the features depended on the sensor location, for instance, feature
1, 2 16 had highest occurrence for wrist sensor, whereas, feature 23, 24 and 25 had
highest occurrence for ankle sensor.
Table 4.10 shows the number of selected features for each patient and for each
sensor location. Number of significant features was about 50 from the 69 features
extracted for each sensor. However, about 20 features were selected for patient 2, 11
and 12 using the ankle sensor, and 5 and 26 features were selected for patient 6 and
10, respectively, using the wrist sensor.
Furthermore, Significant feature as proposed by [28] was selected to show the
variability between patients in respect to the severity of PD symptoms. This feature
was the percentage of the powers for frequencies > 4 Hz. Figure 4.8 shows the box
plots of the log of the feature for three patients and two states. For each patient the
median of the two state are separable, but the median of ON and OFF states for two
patients can overlap such as the ON of patient 12 that overlap with OFF state of
patient 1 and 4.
4.5 Comparison to Other Studies
As mentioned in the literature review, many studies were published to discriminate
between OFF and ON medication states. Summary of these methods is shown in
Table 4.11. This section compares between the results of the published methods
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Figure 4.7: The percentage of occurrence of the significant features for at least one of the
three axes of sensors mounted on wrist, trunk and ankle to the total number of patients
in dataset 1 which is twelve. The features are 1-average jerk, 2-Peak-to-peak, 3-Signal
power 1-4 Hz, 4-Signal power 4-6 Hz, 5-Signal power 0.5-15 Hz, 6-Percentage of the powers
for frequencies > 4Hz, 7-Temporal Shannon entropy, 8-Standard deviation, 9-The number
of autocorrelation peaks, 10-The sum of autocorrelation peaks, 11-First autocorrelation
peak, 12-Lag of the first autocorrelation peak, 13-Gini Index, 14-Sample entropy, 15-Mean
16-Skewness, 17-Kurtosis, 18-Spectral entropy, 19-The peak in the power spectral density,
20-Dominant frequency, 21-The second peak in the power spectral density, 22-Secondary
frequency, 23-Cross-correlation between X and Y axes, 24-Cross-correlation between X and
Z axes, and 25-Cross-correlation between Y and Z axes.
69
CHAPTER 4. RESULTS AND DISCUSSIONS
Table 4.10: The number of the selected features for each patient and for each sensor
location. Selected features have p-value < 5% significant level as a result of the statistical
analysis on the training data for each patient separately, and all the patients (shown in last
row). Number of selected features in bold represents relatively low number of significant
feature for that location.
Patient #
# Selected Features for
Each Location
Total #
Selected Features
Wrist Trunk Ankle
1 52 58 67 177
2 61 55 22 138
3 51 46 52 149
4 51 55 69 175
5 41 48 62 151
6 5 50 45 100
7 53 64 63 180
8 25 28 27 80
9 47 30 43 120
10 26 54 38 118
11 56 57 14 127
12 60 61 21 142
All Patients 59 57 58 174
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Figure 4.8: The box plots of the log of the feature (percentage of the powers for frequencies
> 4 Hz) for three patients and two states. The training data used to extract the feature
is four activities (ambulation, drinking, arm resting and dressing) from two rounds, one for
each MS. The dotted red rectangle shows the overlap between the medians of OFF state for
patient 4 and ON state of patient 12.
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that are activity-independent with the proposed patient-specific classification method
using SVM that is also activity-independent. The average accuracy, sensitivity and
specificity for the this method were 77.26, 83.03, and 75.84, respectively, for the first
dataset, and 82.09, 81.17 and 81.11 for the second dataset.
Hoff et al. proposed activity independent method based on 7 accelerometers
mounted on upper and lower externalities [27]. They validated their method 24
hours data for 15 patients and they obtained sensitivity (60%-71%) and specificity
(66%-76%) which are lower than the results in this thesis.
Salarian et al. published the results of medication state detection method that
was based on five accelerometer and gyroscope sensors and was trained and testing
using subject-based leave-one-out cross-validation on three to six hours recordings for
13 patients [9]. The minimum average change in UPDRS score was 16. They yielded
Sensitivity 90.1% and specificity 76.3%. To make a fair comparison, the results of
patients with average change in UPDRS score > 15 for both datasets (8 patients) were
determined which are accuracy 94.86%, sensitivity 91.94% and specificity 96.83%.
This result shows the correlation between the UPDRS score and good prediction and
it is higher than the results of Salarian et al. study.
Khan et al. suggested using a method based on SVM with RBF kernel to detect
hand and leg tremor, dyskinesias and ON state with dyskinesia [17]. They used
accelerometer sensor mounted on the waist to train the classifier using simulated
data and to test on 12 PD patients with mid to late stage disease. They reported
72% accuracy which is lower than the overall classification accuracy in this thesis for
dataset 1 and 2.
Hammerla et al. proposed using two sequences of Restricted Boltzmann Machines
to detect if the PD patient is asleep, in ON or OFF state or having troublesome
dyskinesia based on two accelerometers worn on each wrist [31]. They trained and
validated their model on overall 32 PD patients who were performing different activ-
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Table 4.11: Summary of the approaches in the published literature proposed to classify
the medication states, in addition to summary of patient-specific classification using SVM
proposed in this thesis.
References # Sensors # Patients
Data Duration
for Each Patient
Classification
Method
Activity-dependent
Model (Yes, No)
Patient-Specific
(Yes, No, Partial)
Results
Hoff et al. [27]
7 uni-axial
accelerometers
15 24 hours
Linear
discriminant
No Yes
Sens.: 60%-71%
Spec.: 66%-76%
Keijsers et al. [28]
One tri-axial
accelerometer
23 About 3 hours
Linear discriminant
and ANN
Yes
(excluding walking)
Partial (Tremor,
and non-tremor
groups)
Sens.: 97%
Spec.: 97%
Salarian et al. [9]
5 sensors
(gyroscopes
and
accelerometers)
13
Three to six
hours
Logistic regression No No
Sens.: 90.1%
Spec.: 76.3%
Sama et al. [24]
One tri-axial
accelerometer
20 About 1 hour
SVM and
linear discriminant
Yes (gait) No
Sens.: 84%
Spec.: 90%
Acc.: 94%
Khan et al. [17]
One tri-axial
accelerometer
12 About 1 hour SVM No No Acc.: 72%
Perez-Lopez et al. [29]
One tri-axial
accelerometer
7 About 6 hours Linear discriminant
Yes (walking and
not walking for
bradykinesia and
dyskinesia detection
,respectively)
Partial (Threshold
on Bradykinesia )
Sens.: 99.9%
Spec.: 99.9%
Rodriguez-
Molinero et al. [30]
One tri-axial
accelerometer
35
About 1.4 -
5.5 hours
Linear discriminant Yes (walking) Yes
Sens.: 96%
Spec.: 94%
Hammerla et al. [31]
Two tri-axial
accelerometer
32
4 hours (in lab)
1 week (in home)
Restricted
Boltzmann Machines
No No
In home, mean
f1-score: 60%
In lab, mean
f1-score: 76%
Fisher et al. [32]
Two tri-axial
accelerometer
32
4 hours (in lab)
1 week (in home)
ANN No No
In home,
Sens.: 50%
Spec.: 83%
In lab,
Sens.: 60%
Spec.: 83%
Ramji,
Hssayeni et al. [34, 68]
Three tri-axial
gyroscopes
18
Dataset 1:
15 minutes
Dataset 2:
about 2 hours
Semi-supervised
using k-means
and
supervised
using SVM
No Yes Acc.: 80%
Proposed
1, 2, or 3
tri-axial gyro.
based on change
in UPDRS for
each patient
19
Dataset 1:
15 minutes
Dataset 2:
about 2 hours
SVM with fuzzy
classification
No Yes
Acc.:80%
Sens.: 82%
Spec.: 78%
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ities for about 4 hours in the lab and for 1 week in the home. They reported peak
mean f1-score 0.76 for 7-fold cross-validation on lab data, and poor generalization
to home data. Using stratified 7-fold cross-validation instead of using subject-based
cross-validation might lead to high validation accuracy and low testing accuracy. In
this thesis, mean f1-score was calculated for each of the patients in dataset 2 using
patient-specific method, and it was (0.94, 0.62, 0.5, 0.99, 0.76, and 0.6) with a peak
of 0.99.
Fisher et al. reported the results of using ANN to detect if the PD patient is
asleep, in ON or OFF state or having troublesome dyskinesia. The same data and
validation procedure were used in the study of Hammerla et al. [31] were used in
Fisher et al. study. Average 55% sensitivity of OFF and specificity of OFF 82% on
lab and home data were obtained. In this thesis average sensitivity and specificity of
OFF state for both dataset were 82.1 and 78.48, respectively.
In recent study, Vegnish proposed patient-specific semi-supervised classification
using k-means that was based on tensor decomposition of multi-channels of three
gyroscope sensors. Dataset 1 and 2 used in this thesis were used in [34]. He reported
average accuracy of 80% for both datasets which is approximately equal to 79.68%
accuracy in this thesis. The advantage of this thesis is using lower number of sensors
for the majority of patients.
4.6 Directional Information vs. Magnitude
Analysis of the directional information was performed to check the importance of
using X, Y and Z for each sensor instead of using their magnitudes. Training data for
the patient-specific classifiers (refer to Section 4.3) was used in this analysis. First,
feature selection was performed based on the statistical analysis proposed in Section
3.2.3.1 on the features extracted from X, Y and Z axes or from the magnitude of
these axes for each patient and for the sensors mounted on wrist, trunk, and ankle.
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After finding the number of significant features, it was found that at least 5 features
were significant if they were extracted from X, Y or Z signals for each of the sensors
and not significant if they were extracted from the axes magnitude as shown in Table
4.12.
Additional experiment was performed to inspect the effect of extracting significant
features from the axes and not from their magnitudes. In this experiment, patient-
specific SVM classifier (refer to Section 4.3) was trained and testing separately on
significant features extracted from X, Y and Z and from their magnitudes. Figure
4.9 shows the results of this experiment for all the permutations of wrist, trunk and
ankle sensors. The average classification sensitivity of the OFF state after training
patient-specific SVM model on features extracted from X, Y and Z signals was higher
than the sensitivity of training and testing on features extracted from the magnitude
of the axes. The only cases where the sensitivity of using the magnitude was higher
were using the signals of the ankle sensor or trunk and ankle sensors. The same
case for OFF specificity, using the axes individually instead of their magnitude led
to higher specificity, except the case where the magnitude of the axes’ signals from
wrist or wrist and trunk sensors was used.
Inspecting the accuracy in Figure 4.9 indicates that using X, Y, and Z signals
resulted in higher or approximately equal accuracy than using their magnitude for
all the sensor combinations, except the case of using only the wrist sensor. As it was
mentioned before, higher specificity was obtained using the magnitude and because
the time for the ON state was higher than the time for OFF state in the testing data,
thus the accuracy was higher despite that the sensitivity using the three axes was
higher than using the magnitude. To sum up, maintaining the directional information
by extracted features from X, Y and Z directly resulted in better overall sensitivity
and specificity.
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Table 4.12: The number of significant features that are selected using the statistical anal-
ysis on features extracted from X, Y and Z axes or from the magnitude of these axes for
each patient and for the sensors mounted on wrist, trunk, and ankle. This table also shows
number of features that were significant if they were extracted from X, Y or Z signals for
each of the sensors and not significant if they were extracted from their magnitude, and vice
versa.
Patient #
# significant
features using
x, y and z axes
# significant
features using
x, y or z and
not using
the magnitude
# significant
features using
the magnitude
of the 3 axes
# significant
features using
the magnitude
and not using
x, y or z
1 177 6 67 1
2 138 12 22 0
3 149 6 52 2
4 175 8 69 0
5 151 7 62 1
6 100 13 45 3
7 180 5 63 0
8 80 19 27 6
9 120 21 43 2
10 118 15 38 2
11 127 13 14 1
12 142 16 21 2
76
CHAPTER 4. RESULTS AND DISCUSSIONS
A
cc
u
ra
cy
Wrist
Using features based on the 
magnitude of  X, Y, and Z signals
Using features based on 
X, Y, and Z signals
O
F
F
 S
en
si
ti
v
it
y
O
F
F
 S
p
ec
if
ic
it
y
Trunk Ankle Wrist and 
Trunk
Wrist and 
Ankle
Trunk and 
Ankle
Wrist, 
Trunk and 
Ankle
Figure 4.9: The average classification results of the testing data after training patient-
specific SVM model on features extracted from X, Y, and Z signals vs. features extracted
from their magnitude signal. The results of using single or multiple sensors are presented.
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Conclusion and Future Work
Patients with mid-stage and advanced Parkinson’s disease are facing motor fluctua-
tions that significantly affect their way of living and thus they are a major focus of
clinical management. In this thesis, four supervised and semi-supervised classification
approaches are developed to automatically assess the ON and OFF medication states
using wearable sensors while PD patients are engaging in a variety of daily living ac-
tivities. These methods are supervised learning using SVM with fuzzy classification,
semi-supervised learning using k-means or using SOTM with fuzzy classification, and
supervised classification using LSTM as a deep learning method.
Multiple temporal and spectral features that are relevant to PD symptoms are
extracted from the three axes of gyroscope sensors. After performing dimensionality
reduction, the features are passed through to the first three methods, whereas the
signals of gyroscope’s axes are used to train and test LSTM networks without apply-
ing prior feature extraction. The developed methods were evaluated on two datasets
that included recordings of 19 PD patients. Two scenarios were considered: general
training/classification and patient-specific where the former trains and tests the al-
gorithm using subject-based leave-one-out cross-validation, and the latter trains and
tests the algorithm for each patient individually. Based on the reported results, the
following were concluded:
• The results of generally-trained SVM showed that in general using two
sensors mounted on ankle and trunk or ankle and thigh had the highest accuracy.
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However, inspecting the results of using combinations of gyroscopes mounted on
wrist, trunk, thigh, or ankle showed that one sensor or different sensor placement
led to higher accuracy for specific patients. Therefore, there is a need for an
algorithm that adapts with this variability between patients.
• The results of generally-trained LSTM showed LSTM generalization and
adaptation ability using only one sensor mounted on ankle. It obtained signif-
icant accuracy for some of the patients for whom generally-trained SVM was
not able to classify their medication states correctly.
• The algorithm based on LSTM performed better than SVM with over-
all 74.91%, 69.42%, and 80.55% for accuracy, sensitivity, and specificity, re-
spectively, when only one sensor mounted on the ankle was used in the general
training scenario. In addition, LSTM network for both datasets yielded the
highest specificity of the OFF state. Those promising results show the poten-
tial outcome of developing deep learning methods in this field.
• Patient-specific SVM outperformed the proposed semi-supervised method
using k-means or SOTM despite the small amount of data used for train-
ing. The second high performance in patient-specific scenario was for semi-
supervised method using SOTM.
• Number of sensors and their placement for each patient that associated
with the highest accuracy in patient-specific scenario were correlated with the
average change in UPDRS score between OFF and ON state for each patient and
the presence of rest tremor. Therefore, a method for selected the number and
placement of gyroscopes were proposed and integrated with the patient-specific
algorithm using SVM.
• In the comparison between generally-trained SVM and LSTM with
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patient-specific SVM classifier, Patient-specific SVM outperformed generally-
trained SVM and LSTM by about 5% accuracy for both datasets.
• Performing feature analysis showed the variability between PD patients and
also showed retaining the directional information by using X, Y, and Z instead
of their magnitude is beneficial for medication state classification.
To sum up, activity-independent classification using patient-specific SVM classifier
was selected as the winning method. The selection of the number of sensors and
their placement on patient’s body depended on the average change in UPDRS score
between ON and OFF medication states and the presence of tremor for that patient.
Average accuracy, sensitivity and specificity of OFF state for both datasets were
80%, 82% and 78% using the proposed patient-specific SVM classifier. For group of
patients who had change in their UPDRS score between the two states more than 15,
classification results were very high which were accuracy 94.86%, sensitivity 91.94%
and specificity 96.83%. Comparing the proposed approach with other studies showed
it had either the highest performance or equal performance with the advantage of
using lower number of sensors. These results are promising and thus this algorithm
can be potentially used in routine clinical practice to improve the quality of this group
of PD patients.
5.1 Future Work
The limitation of the patient-specific algorithm is the need for prior knowledge about
each patient and training data, thus there is a requirement for developing algorithm
that can generally adapt to the X, Y, and Z data of gyroscope or accelerometer
sensors mounted on the limb that is most affected by PD symptoms. This means
training a model that can predict medication states from signals regardless of their
sensors placement. In other words, train a model that is independent on patient’s
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activities and sensor’s number or placement. LSTM performance on these small
datasets shows its ability for adaptation and generalization. Therefore, our future
work includes developing generally-trained LSTM model that can predict medication
states with significant accuracy.
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